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Introduction: Reference ranges for cardiac measurement are available for adults, children and term infants 
but the same cannot be said for preterm or small for gestational age (SGA) infants surviving as a result of 
modern intensive care units.  
No published data of reference ranges for preterm infants exists for the South African population. Infants 
with congenital heart disease are twice as likely to be small for their gestational age and these reference 
ranges may affect clinical management decisions, therapeutic response and prognosis of these neonates.  The 
aim was thus to establish reference ranges for cardiac dimensions and functional values for preterm and low 
birth weight infants for central South Africa and compare them with international standards.  
Methods: A total of 290 infants of less than 34 weeks of age and weighing less than 2500g at birth were 
examined during a twelve month period by echocardiography during the first 0-28 days of life. The study 
assessed normative cardiac measurements divided in M-Mode, 2-D and functional measurement for these 
infants in 3 weight groups.   
Exclusion criteria were applied to any condition affecting the size and functionality of the cardiac system. The 
following dimensions were measured:  Standard M-Mode values for the left ventricle, 2D measurements of 
valve mitral and tricuspid orifices, as well as functional assessments including Shortening fraction (SF %), 
Ejection fraction (EF %), and Muscle performance Index (MPI)-index of the Left and Right ventricle. 
Measurements were done by the leading edge methodology following the ASE recommendations. 
A longitudinal study was also done to examine changes in these indices over the first month- on day 14 and 
day 28 of life. Interobserver differences were calculated for the variability between measurements of a single 
scan- 25 babies were re-measured and produced good repeatability. 
Results: 290 infants were included to produce Referance ranges of measurements (means and standard 
deviations) for 3 weight groups namely: <0.999g, 1000-1499g, and 1500g – 2500g.  
The gestational age’s ranges between 26-38 weeks with a median of 31 weeks, gender distribution was 
almost equal with a slight female preponderance. Body surface area ranged from a minimum from 0.076 m² 
and a maximum of 0.184 m², the body weight ranged between a minimum of 690g and a maximum of 2500g 
with a median of 1360g.  
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Discussion: The left ventricular diastolic and systolic, interventricular septum, posterior wall, aortic and left 
atrium dimensions showed a proportionate increase in diameter with an increase in body weight There were 
no differences in cardiac dimensions between Small for Gestational age” (SGA) versus “Average for 
Gestational age” (AGA). Gender and race played no role in any functional measurements or with the cardiac 
sizes. Weight correlated well with BSA and the data suggest that weight only can be used to develop tables for 
clinical use.  
Cardiac chambers increased with BSA and weight and functional measurements stayed the same throughout 
the weight groups. Systolic and global functions were remarkably similar and constant throughout weight 
categories. . The longitudinal study also confirmed that the values are applicable to all low birth weight 
infants up to 28 days of age. 
Differences existed between some of the average South African infant’s cardiac chambers and international 
values. The Inter Ventricular Septum (IVS) and Posterior Wall (PW) measured thicker and the Left Atrium 
larger. This could be due to numerous factors that should be investigated further.  
Conclusion: The study emphasized the profound effect of growth and weight gain on the cardiac structure 
and that population specific reference values should therefore be developed and used.  
 
 
 
  
 
 
 
 
 
Inleiding: Kardiale verwysings waardes vir kardiale metings is beskikbaar vir volwassenes, kinders en 
volterm babas. Dieselfde kan nie gesê word vir vroeggebore of klein vir swangerskapsduur babas wat oorleef 
as gevolg van moderne intensiewe sorg eenhede nie. Geen gepubliseerde data vir hierdie groep babas bestaan 
vir die Suid-Afrikaanse bevolking nie. Babas met kongenitale hartsiektes is twee keer meer geneig om klein te 
wees vir hulle gestasie-ouderdom. Hartgroottes beinvloed kliniese besluitneming t.o.v. terapeutiese 
beplanning asook prognose van hierdie groep babas.  
Die doel van hierdie studie was die daarstelling van verwysingswaardes vir hartgroottes en fuksies vir 
vroeggebore en lae geboortegewig babas woonagtig in sentraal Suid-Afrika en dit te vergelyk met 
internasionale verwysingswaardes. 
Metodes: 'n Totaal van 290 babas jonger as 34 weke met ‘n gewig van minder as 2500g by geboorte is 
gedurende 'n tydperk van twaalf maande met behulp van eggokardiografie ondersoek gedurende die eerste 
0-28 lewensdae.  
Die studie het normale kardiale en funksionele afmetings vir babas in 3 verskillende gewigs groepe bepaal. 
Enige veranderlike wat die grootte en die funksie van die kardiale stelsel kon beinvloed is as uitsluitings 
kriteria toegepas. Die volgende afmetings is bepaal: Standard M-mode van die linker ventrikel, 2D-mates van 
die mitraal en trikuspidale klep openinge, sowel as funksionele assessering, bestaande uit verkortings fraksie 
(SF%), uitwerpfraksie (EF%), asook globale miokard werksverigtings indeks(MPI) van die linker en regter 
ventrikels.  
Metings het voldoen aan ASE aanbevelings.'n Longitudinale studie is ook gedoen om die veranderinge in 
hierdie waardes te ondersoek oor die eerste maand van lewe. Interondersoeker variasie is ook bereken ten 
einde herhaalbaarheid van resultate te bevestig.  
Resultate: 290 babas is ingesluit om verwysings waardes van metings (gemiddeldes en standaardafwykings) 
vir die volgende drie gewigsgroepe te bepaal naamlik: <0.999g, 1000-1499g, en 1500g - 2500g.  
Die gestasie-ouderdom het gewissel tussen 26-38 weke met 'n mediaan van 31 weke.  Geslag verspreiding 
was byna gelyk met effens meer vroulike babas. Liggaams oppervlak het gewissel vanaf 'n minimum van 
0,076 m² tot 'n maksimum van 0,184 m², liggaams gewig het gewissel van 690g tot 2500g met 'n mediaan van 
1360g. 
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Bespreking: Die M-mode hart afmetings het 'n proporsionele toename in deursnee met 'n toename in 
liggaamsmassa getoon. Sistoliese en globale funksies was merkwaardig konstant oor al die gewigs kategorieë. 
Daar was geen verskille in die hart afmetings vir klein vir gestasie-ouderdom teenoor normaal vir gestasie-
ouderdom nie. Geslag en ras het geen rol gespeel in die funksionele metings of met hart groottes nie. Gewig 
het byna ‘n perfekte korrelasie met liggaams massa oppervlak getoon wat daarop dui dat enige een van die 
twee gebruik kan word. 
 Die longitudinale studie het ook bevestig dat hierdie afmetings van toepassing is op alle lae geboortegewig 
babas vanaf dag een tot en met ouderdom van 28 dae. Subtiele verskille is gevind tussen sommige Suid-
Afrikaanse babas se hart kamer afmetings en internasionale waardes. Die inter ventrikulêre septum en 
posterior wand het dikker gemeet en die linker atrium asook aorta groter. Verskeie faktore kan hiertoe lei en 
moet verder ondersoek word. 
Gevolgtrekking: Ten slotte beklemtoon hierdie studie die diepgaande effek van groei en gewigstoename op 
die hart grootte en funksies  asook die feit en belang dat bevolking spesifieke verwysing waardes ontwikkel 
moet word.   
 
 
 
 
  
 
 
 
 
 
Ejection Fraction (EF) 
 
“The volume of blood ejected from the ventricle during each systole 
can be expressed as a percentage of the end- diastolic volume. This 
gives the ejection fraction of the heart. The normal range for the left 
ventricle ejection fraction is between 52% - 75% (Silverman, 1993). 
 
Shortening fraction (SF) 
 
“Represents the transverse diameter fractional shortening of the left 
ventricle at the level of the mitral valve and are generally considered 
as a very reliable index of left ventricular systolic performance 
(Silverman, 1993). 
 
Left ventricle end- diastolic 
diameter (LVEDD) 
 
“Left ventricle internal diameter at end – diastole” (Silverman, 1993). 
 
Left ventricle end systolic 
diameter (LVESD) 
 
“Left ventricle internal diameter at the end – systole” (Silverman, 
1993). 
 
M-mode Echocardiography 
 
“In the M-mode format, the B- Line sweeps across the face of a 
cathode ray tube. Because of the persistence of the phosphor of the 
tube, the B-mode dots leave a trail as they move. This trail depicts the 
motion of the intra cardiac structure relative to time, also known as 
time- motion presentation” (Silverman, 1993). 
Hemodynamic 
 
“Hemodynamic refers to the investigation of the physical principles of 
blood flow and the circulation” (Silverman, 1993). 
 
 
Premature birth 
 
“Refers to the birth of an infant that haven’t yet reached gestational 
maturity” (Godfrey & Baum 1979; Subramanian, 2009). 
Low birth weight 
(LBW) infants 
 
“Infants (less than 2500g) who are mostly but not exclusively, 
preterm babies” (Godfrey & Baum 1979; Subramanian, 2009). 
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Very Low Birth Weight 
(VLBW) infants 
 
“Infants (less than 1500g) who are mostly but not exclusively, 
preterm babies“ (Godfrey & Baum 1979; Subramanian, 2009). 
 
Extremely Low Birth Weight 
(ELBW) infants 
 
“Infants (less than 1000g) who are mostly but not exclusively, 
preterm babies“ (Godfrey & Baum 1979; Subramanian, 2009). 
 
Small for Gestational Age (SGA) 
 
“Defined as babies whose birth weight lies below the 10th percentile 
for a specific gestational age, they may be full term or preterm 
infants” (Goldenberg et al., 2008) and who are classified as infants 
with a low birth weight. 
 
Myocardial Performance 
Index (MPI) 
 
“Is a non-invasive, quantitative, Doppler-based measurement of 
global cardiac function, which integrates systolic and diastolic 
function (Tei, Ling, Hodge, Bailey, Oh, Rodeheffer, Tajik & Seward, 
1995). 
 
Intrauterine Growth Retardation 
(IUGR) 
 
When fetal size is less than expected, the condition is known as 
intrauterine growth retardation (IUGR) or also known as fetal growth 
restriction (FGR) (Godfrey & Baum 1979). 
 
Ballard Score 
 
Gestational age is determined by the Ballard Score (Ballard, Khoury, 
Wedig, Wang, Eilers-Walsman & Lipp, 1991). The method uses both 
neurological and external features to determine gestational age. Each 
feature is given a score and these scores are added up to give a final 
score (Appendix E). 
 
Average for gestational age (AGA) 
 
“Defined as babies whose birth weight is within the normal 
percentiles for a specific gestational age, they may be full term or 
preterm infants” (Godfrey & Baum 1979). 
  
 
 
 
 
 
% Percentage 
= Equals 
 > More than 
2D Two – dimensional  
AGA Average for gestational age 
ASE American Society of Echocardiography 
BMI Body Mass Index 
BSA Body surface area 
Cm Centimeters 
CO2 Carbon dioxide 
ECG  Electro cardio graph 
ELBW Extremely low birth weight 
et al. et alii (and others) 
g Gram 
h Hour 
HMD Hyaline membrane disease 
IUGR Intra uterine growth restriction 
IVC Inferior vena cava 
IVS Interventricular Septum 
kg Kilogram 
LA Left atrium 
LBW Low birth weight 
LV Left ventricle 
LVEDD Left ventricle end diastolic diameter 
LVEF Left ventricle Ejection  fraction 
LVESD Left ventricle end systolic diameter 
m² square meter 
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mm Millimeter 
M-mode Motion mode 
N Number of Samples Analyzed 
P Statistical significance 
PB Preterm birth 
PDA Patent ductus arteriosus 
PW Posterior Wall 
RDS Respiratory distress 
RV Right ventricle 
SF Shortening fraction 
SGA Small for gestational age 
SVC Superior vena cava 
UFS University of the Free State 
VLBW Very low birth weight 
 
 
 
 
 
 
  
 
 
 
 
TABLE           PAGE 
Table 2.1 M-Mode Echocardiographic measurements                       21 
Table 2.2 Cardiac Structures & Detectable Abnormalities                22 
Table 4.1 Anthropometric data for the entire study population                43 
Table 4.2 Anthropometric data per weight category                45 
Table 4.3 M-Mode: Group 1 (Weight Category <0.999g)                48 
Table 4.4 M-Mode: Group 2 (Weight Category 1000-1499g)                49 
Table 4.5 M-Mode: Group 3 (Weight Category 1500-2500g)                49 
Table 4.6 M-Mode: AGA vs. SGA Group 1 (Weight Category <0.999g)                50 
Table 4.7 M-Mode: AGA vs. SGA Group 2 (Weight Category 1000-1499g)                50 
Table 4.8 M-Mode: AGA vs. SGA Group 3 (Weight Category 1500-2500g)                51 
Table 4.9 M-Mode: Left ventricle internal dimensions for clinical use                51 
Table 4.10 
Mitral & Tricuspid annulus: Group 1  
(Weight Category <0.999g) 
               54 
Table 4.11 
Mitral & Tricuspid annulus: Group 2  
(Weight Category 1000-1499g) 
               54 
Table 4.12 
Mitral & Tricuspid annulus: Group 3  
(Weight Category 1500-2500g) 
               54 
Table 4.13 
Mitral & Tricuspid annulus: AGA vs. SGA Group 1 
(Weight Category <0.999g) 
               55 
Table 4.14 
Mitral & Tricuspid annulus: AGA vs. SGA Group 2 
(Weight Category 1000-1499g) 
               55 
Table 4.15 
Mitral & Tricuspid annulus: AGA vs. SGA Group 3 
(Weight Category 1500-2500g) 
               55 
Table 4.16 Mitral and Tricuspid valve annular diameters for clinical use                56 
Table 4.17 
Shortening & Ejection Fraction: Group 1 
 (Weight Category <0.999g) 
               57 
Table 4.18 
Shortening & Ejection Fraction: Group 2  
(Weight Category 1000-1499g) 
               59 
LIST OF TABLES 
 
  
XX 
Table 4.19 
Shortening & Ejection Fraction: Group 3 
(Weight Category 1500-2500g) 
               59 
Table 4.20 
Shortening & Ejection Fraction: AGA vs. SGA Group 1  
(Weight Category <0.999g) 
               59 
Table 4.21 
Shortening & Ejection Fraction: AGA vs. SGA Group 2 
(Weight Category 1000-1499g) 
               60 
Table 4.22 
Shortening & Ejection Fraction: AGA vs. SGA Group 3  
(Weight Category 1500-2500g) 
               60 
Table 4.23: Shortening and Ejection Fraction for clinical use                60 
Table 4.24 
MPI Left & Right Ventricle: Group 1  
(Weight Category <0.999g) 
               62 
Table 4.25 
MPI Left & Right Ventricle: Group 2 
(Weight Category 1000-1499g) 
               62 
Table 4.26 
MPI Left & Right Ventricle: Group 3 
(Weight Category 1500-2500g) 
               62 
Table 4.27 
MPI Left & Right Ventricle: AGA vs. SGA Group 1 
(Weight Category <0.999g) 
               62 
Table 4.28 
MPI Left & Right Ventricle: AGA vs. SGA Group 2 
(Weight Category 1000-1499g) 
               63 
Table 4.29 
MPI Left & Right Ventricle: AGA vs. SGA Group 3  
(Weight Category 1500-2500g) 
               63 
Table 4.30 MPI Left and Right ventricle for clinical use                 63 
Table 4.31 Interobserver Differences                70 
Table 4.32 Local vs. International values A                71 
Table 4.33 Local vs. International values B                72 
  
 
 
 
 
 
FIGURE           PAGE 
Figure 2.1  Method used to calculate MPI index                                                                        27 
Figure 3.1 Study Layout                                                                                                                                            35 
Figure 4.1 Gender Distribution                                                                                         43 
Figure 4.2 Weight Categorization                                                                                    44 
Figure 4.3 Gender distributions per Category                                                             45 
Figure 4.4 Weight VS. Body Surface Area (BSA)                                                               46 
Figure 4.5 SGA versus AGA infants per Group 1-3                                                          47 
Figure 4.6 Linear regression analyses for LVEDD measurements                           53 
Figure 4.7 Linear regression analysis for all Mitral valve annulus measurements                                                                                       56
Figure 4.8 
Linear regression analysis for all tricuspid valve annulus 
measurements                                                                                       
               57 
Figure 4.9 
Linear regression analysis between Mitral valve annulus and 
Tricuspid valve annulus                                                           
               57 
Figure 4.10 Linear regression analyses for all SF % measurements                       61 
Figure 4.11 
Linear regression analysis for Left ventricle MPI index values versus 
weight                                                                                                                                                      
               64 
Figure 4.12 Linear regression analysis for Right ventricle MPI versus weight                       64 
Figure 4.13 MPI Left ventricle versus right ventricle                                                                                 65 
Figure 4.14 Left ventricle MPI versus SF                                                                                                            65 
Figure 4.15 Cardiac findings                                                                                                                                   66 
Figure 4.16 Weight gain 0-28 days                                                                                                                      67 
 LIST OF FIGURES 
 
  
XXII 
Figure 4.17 Aortic root diameter 0-28 days                                                                            67 
Figure 4.18 Mitral valve annulus 0-28 days                                                                                                                  68 
Figure 4.19 LVEDD 0-28 days                                                                                                                                  68 
Figure 4.20 Shortening fraction 0-28 days                                                                                                                  69
 
 
 
 
 
 
 
Chapter 1 / Introduction    
 
1 
 
 
 
 
 
The recognition and identification of serious cardiac diseases in the newborn is challenging (Godfrey & Baum 
1979; Moss & Adams 1968).  Major structural heart and pulmonary diseases may have profound effects on 
cardiac chambers and sizes. The availability and usefulness of echocardiography has fostered its popularity as 
a diagnostic test. A major advantage of echocardiography in the assessment of fragile, unstable premature or 
low birth weight infants is the fact that it’s non-invasive, easy to use and has no known risks or side effects 
(Silverman, 1993). Linear measurements from M-Mode and 2D images have proven to be reproducible with 
low intra-observer and inter-observer variability (Godfrey & Baum 1979). 
 
The assessment of cardiac chamber dimensions, great arteries and veins are important to distinguish 
abnormal dimensions from normal, especially in children with dysfunction where the heart chambers may be 
hypoplastic or enlarged (Moss & Adams 1968). 
 
The importance of echocardiography, to provide hemodynamic information has markedly increased. Doppler 
flow studies provide direct assessment of blood flow in the cardiovascular system, and this can provide useful 
information concerning intra cardiac pressures and pressure gradients (Godfrey & Baum 1979; Moss & 
Adams 1968). 
 
An understanding of fetal hemodynamic as well as the acute and chronic changes that occur with transition to 
the newborn circulation are important for the care of normal newborns and are crucial for the recognition, 
diagnosis, and management of a newborn with significant congenital heart disease (Lundstrom, 1974; Moss & 
Adams 1968).  The premature cardiovascular system in preterm infants often seems unstable and fragile, 
especially in the early neonatal period. The myocardium of preterm infants can easily be influenced by 
hypoxia and ischemia, resulting in systemic and pulmonary hypo-perfusion. In the critically ill, very low birth 
weight infants, reduced left ventricular function, decreased left ventricular output and persistence of 
pulmonary hypertension have been reported (Lundstrom, 1974; Moss & Adams 1968). 
 
Fetal right ventricular function differs markedly from that of the adult in several important aspects. Before 
birth, the ductus arteriosus allows the fetal heart to function as two pumps in parallel, with the dominant 
right ventricle (RV) pumping double the volume of blood than the left ventricle (LV). Only a small portion of 
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RV output passes into the pulmonary vascular bed (8-10%), whereas the majority of RV output bypasses the 
fetal lung and flows into the aorta via the ductus arteriosus in the near term fetus (Moss & Adams 1968). 
 
Pulmonary blood flow increases up to 10 fold within minutes of birth as pulmonary vasculature resistance 
decreases to 10% of the fetal level. Failure of the newborn to progress naturally through these transitions, as 
may occur with premature birth or persistent pulmonary hypertension, may result in ventricular vascular 
interactions that may be detrimental (Godfrey & Baum 1979; Moss & Adams 1968). 
 
Infants with congenital heart disease are approximately twice as likely to be small for gestational age and this 
may affect clinical management decisions, therapeutic response and prognosis of these neonates (Godfrey & 
Baum 1979; Chesler, 1986;). Reference echocardiographic values for full term infants have been well 
established [Roge, Silverman, Hart & Ray (1978); Walther, Siassi, King & Wupy (1986); Tan, Silverman, 
Hoffman, Legas & Schmidt (1992); Skelton, Gill & Parsons (1998)] but the same cannot be said for preterm or 
small for gestational age (SGA) infants. Internationally, some series exists [Roge et al., (1978); Walther et al.,( 
1986); Tan et al.,(1992) and Skelton et al., (1998], but they are usually small, and none exist for SGA babies.  
Of note, no published data of reference ranges for preterm infants exists for the South African population. 
 
The aim of this study was to establish reference echocardiographic values for premature & low birth weight 
infants, based on cross sectional echocardiographic measurements. 
 
 
 
Chapter 2 / Literature Review   3 
 
 
 
 
 
2.1 EPIDEMIOLOGY AND CLASSIFICATION OF PREMATURE AND 
LOW-BIRTH WEIGHT INFANTS  
A "premature" infant can be defined as one that has not yet reached the level of mature development, and is 
born before 37 weeks gestational age (Matthew & MacDorman 2006). Gestational age is determined by the 
Ballard Score (Ballard, Khoury, Wedig, Wang, Eilers-Walsman & Lipp, 1991). The method uses both 
neurological and external features to determine gestational age. Each feature is given a score and these scores 
are added up to give a final score (Appendix E).  Premature birth, commonly used as a synonym for preterm 
birth, refers to the birth of an infant that haven’t yet reached gestational maturity (Godfrey & Baum 1979; 
Subramanian, 2009). Premature infants are at greater risk for short and long term complications, including 
disabilities and impediments in growth and mental development. Significant progress has been made in the 
care of premature infants, but not in reducing the prevalence of preterm birth (Goldenberg, Hauth & Andrews 
2000; Subramanian, 2009). 
 
Preterm birth is still a major cause of neonatal mortality in developed countries. Internationally, it is 
estimated that in 2005, 9.6% of all births were preterm which translates to about 12.9million preterm births 
(Bulletin of the World Health Organization 2010). 
 
No data have been published on the global incidence of preterm birth. Preterm birth rates from developed 
countries, such as the United Kingdom, the United States and Scandinavian countries, have shown a dramatic 
rise over the past 20 years (Bulletin of the World Health Organization, 2010). 
 
Factors possibly contributing to but not completely explaining this upward trend, include increased rates of 
multiple births, greater use of assisted reproduction techniques, increases in the proportion of births among 
women over 34 years of age and changes in clinical practices, such as greater use of elective Caesarean 
section (Bulletin of the World Health Organization, 2010). 
 
About 0.5 million preterm births occurred in Europe and the same number in North America, while 
0.9 million occurred in Latin America and the Caribbean. The highest rates occurred in Africa and North 
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America, where 11.9% and 10.6%, respectively, of the births were preterm. Europe, where 6.2% of the births 
were preterm, had the lowest rate (Bulletin of the World Health Organization, 2010). 
 
Approximately 85% of this burden is concentrated in Africa and Asia, where 10.9 million births are preterm. 
The analysis shows that the burden of preterm birth is disproportionately concentrated in Africa and Asia 
(31% and 54%, respectively; Bulletin of the World Health Organization, 2010). 
 
Clearly, different risk factors play a role in the high rates of preterm births indifferent regions. In North 
America, the increasing age of women giving birth, leads to more maternal complications and Caesarean 
sections, and explain the high preterm birth rates. An increase in multiple pregnancies may be the other 
contributing factor (Bulletin of the World Health Organization, 2010). 
 
In Africa, the high prevalence of preterm births can probably be attributed to intrauterine infection, 
suboptimal maternal care, or inadequate drug availability and distribution. Due to the devastating effects of 
preterm births the identification of preventable causes, should be a top priority in the developing world 
(Bulletin of the World Health Organization, 2010). 
 
According to United Nations International Children’s Emergency fund (UNICEF), 22% of all low- birth weight 
infants born in developing countries are born in Africa. They state that the number of low-birth weight 
infants is more than double the number born in developed regions (UNICEF, 2009: Online). 
 
South Africa is rated at a level of 14.6 % for the private sector and the  percentage may increase to as much as 
25% affecting dominantly the lower income group of the public sector (Statistics South Africa, 2011: Online). 
 
2.2  REASONS CONTRIBUTING TO PRETERM BIRTH (PB) 
 
The cause for PB is in many situations elusive and unknown. Numerous factors appear to be associated with 
the development of PB, making the reduction of PB a challenging proposition (Goldenberg et al., 2008). 
 
a) Spontaneous 
 
About forty to forty–five percent of premature infants are due to spontaneous PBs that follows 
preterm labour and 25-30% premature infants are born due to premature rupture of membranes 
(Krupa, Faltin, Cecatti & Souza, 1994). 
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b) Natural response to infections 
 
The exact causes of spontaneous premature membrane rupture are not fully understood. Literature 
suggests that many cases are triggered by the body’s natural response to certain infections including 
those involving amniotic fluid and fetal membranes. However, in about half of all cases of premature 
births, no causes can be demonstrated (Krupa et al., 1994). 
 
c) Obstetrical 
 
The remaining 30-35% are PBs induced for obstetrical reasons (obstetricians may have to deliver the 
baby preterm because of a deteriorating intrauterine environment (i.e. infection, intrauterine growth 
retardation) or significant endangerment of maternal health (e.g. pre-eclampsia; Goldenberg et al., 
2008). 
2.2.1 GLOBAL PERCENTAGES O F PREMATURE INFANTS CLASSIFIED 
ACCORDING TO GESTATIONAL SIZE:  
 5% of PBs occur at less than 28 weeks (extreme prematurity), 
 15% at 28-31 weeks (severe prematurity), 
 20% at 32-33 weeks (moderate prematurity) and 
 60-70% at 34-36 weeks (near term) (Subramanian, 2009). 
2.2.2  CLASSIFICATION BY GESTATIONAL AGE AND WEIGHT 
 
Since weight is easier to determine than gestational age, and weight generally correlates with gestational age, 
infants may be underweight for other reasons than a preterm delivery. 
Low birth weight (LBW) infants (less than 2500g) are mostly but not exclusively, preterm babies. Very Low 
Birth Weight (VLBW) infants have a birth weight of less than 1500g and Extremely Low Birth Weight (ELBW) 
infants weigh less than 1000g. Almost all neonates in these latter two groups are born prematurely 
(Goldenberg et al., 2008; Subramanian 2009: Online). 
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2.2.3 SMALL FOR GESTATIONAL AGE (SGA)  
 
Small for Gestational Age (SGA) infants are classified as infants with a low birth weight, although they may be 
full term or preterm infants (Lundstrom, 1974; Larsen William, 2001). Therefore, these infants do not fall into 
the reference categories specified for the premature infant. SGA infants may have a low weight, but are older 
according to gestational age (they are thus more mature). They can neither be evaluated on their gestational 
age, nor weight, because they are smaller in the weight categories compared to their peers (Lundstrom, 1974; 
Larsen William, 2001). 
2.2.3.1 CHARACTERISTICS OF SGA INFANTS 
 
(a) The infant appears thin and wasted; their skin is loose and dry.  
(b) There is little subcutaneous fat; their face appears shrunken and wrinkled.  
(c) The length and head size may be normal but the head looks really big in comparison to the rest of the 
body (Lundstrom, 1974) 
 
2.2.3.2 CONDITIONS THAT OCCUR MORE FREQUENTLY IN THE SGA INFANT 
 
(a) Asphyxia (a condition arising when the body is deprived of oxygen, causing unconsciousness or 
death, suffocation). They tolerate labour poorly due to the decreased metabolic stores of 
carbohydrates and often needs resuscitation at birth (Lundstrom, 1974; Godfrey & Baum, 1979; 
Larsen William, 2001). 
 
(b) Meconium aspiration (when a newborn inhales fecal discharge during labour or delivery). 
The fetus inhales amniotic fluid containing meconium, or it occurs when the neonate takes his first 
breath and can lead to atelectasis, pneumothorax, or pneumonitis (Lundstrom, 1974; Godfrey & 
Baum, 1979; Larsen William, 2001). 
 
(c) Hypoglycaemia (abnormally low blood glucose usually resulting from excessive insulin or a poor 
diet). This most likely occurs 12 to 48 hours after birth but may also be noted within 6 hours if the 
infant is severely hypoxic and may lead to neurological damage (Lundstrom, 1974; Godfrey & Baum, 
1979; Larsen William, 2001). 
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(d) Hypothermia (a condition in which the core temperature of the body drops below that required for 
normal metabolism and body functions). The development of hypothermia in the SGA infant can be 
attributed to the lack of subcutaneous fat (Lundstrom, 1974; Godfrey & Baum, 1979; Larsen William, 
2001). 
 
(e) Polycythemia (an abnormal increase of haemoglobin in the blood either through reduction of 
plasma volume or the increase in red cell numbers. It may be a primary disease of unknown cause or 
a secondary condition linked to respiratory or circulatory disorder). This is frequently seen when the 
reason for SGA is placental insufficiency (Lundstrom, 1974; Godfrey & Baum, 1979; Larsen William, 
2001). 
 
(f) Congenital anomalies (involves defects on or damage to a developing fetus, it may be the result of 
genetic abnormalities, the intrauterine environment, errors of morphogenesis, or a chromosomal 
abnormality). The genitourinary and cardiovascular systems are most commonly affected in these 
SGA infants (Lundstrom, 1974; Godfrey & Baum, 1979; Larsen William, 2001). 
2.3 THE CIRCULATORY SYSTEM 
2.3.1    THE HUMAN FETAL CIRCULATORY SY STEM 
 
Fetal circulation differs from neonatal, mainly because the lungs are not in use and the fetus obtains oxygen 
and nutrients from the mother through the placenta and the umbilical cord (Chesler, 1986; Agata, Hiraishi, 
Oguchi, Misawa, Horiguchi, Fujino, Yashiro & Shimada, 1991; Klabunde, 2005). 
The placenta at term carries about 40% of the combined ventricular output (Moss & Adams, 1968; Chesler, 
1986). This is augmented by venous return from the lower half of the body to 69% returning via the Inferior 
Vena Cava (IVC), in contrast to 21% returning via the Superior Vena Cava (SVC) and 3% coronary venous 
return. At most, 2% of the SVC return crosses the foramen ovale to enter the left atrium which therefore 
receives 27% of the total output through the IVC and foramen ovale and 7% of the total output as pulmonary 
venous return. Thus 34% of total cardiac output comes to pass through the left ventricle, whereas, 66% 
passes through the right ventricle: one third of this originates from the SVC and the remainder from the IVC 
and coronary sinus. The high fetal pulmonary vascular resistance ensures that only 8 - 10% of the total right 
ventricle output passes to the lungs, the rest traverses the widened patent ductus arteriosus (Moss & Adams, 
1968; Godfrey & Baum, 1979; Chesler, 1986). 
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Blood from the placenta is carried to the fetus via the umbilical vein.  About half of this enters the fetal ductus 
venosus and is carried to the inferior vena cava, while the other half enters the liver. The branch of the 
umbilical vein that supplies the right lobe of the liver first joins with the portal vein. The blood then moves to 
the right atrium of the heart. In the fetus, blood passes from the right atrium to the left atrium through the 
foramen ovale, thus bypassing pulmonary circulation. The blood flows into the left ventricle from where it is 
pumped through the aorta into the body. Some of the blood flows from the aorta through the internal iliac 
arteries to the umbilical arteries, and re-enters the placenta, where carbon dioxide (CO2) and other waste 
products from the fetus are taken up and enter the maternal circulation (Moss & Adams, 1968; Chesler, 1986; 
Klabunde, 2005;). 
The ductus is an important structure during fetal life as it allows unloading of the RV and joins the pulmonary 
trunk to the aorta with a diameter equivalent to the pulmonary artery and larger than the aorta. Premature 
closure of the fetal ductus will result in an immediate increase in afterload of the RV with resultant 
hypertrophy, dysfunction, dilation, tricuspid valve regurgitation, papillary muscle stress, and ischemia, 
sometimes resulting in papillary muscle rupture with flail valve. An increase in pulmonary trunk pressure 
may change blood flow in the high resistance, fluid filled lungs, this pressure leads to hypertrophy of the 
media, causing pulmonary hypertension and post natal persistent pulmonary hypertension of the neonate 
(Gewillig, Brown, De Catte, Debeer, Eyskens, Cossey, Van Schoubroeck, Van Hole & Devlieger, 2009). 
 
Right ventricular function plays a critical role in a number of congenital and acquired cardiac conditions. 
Accurate measurements of RV function are important in planning treatment and predicting prognosis. Until 
recently, RV function has attracted less attention than LV function. The main reasons have been due to the 
lack of understanding of its important role in the circulation and difficulties in assessing its function due to its 
complex anatomy. The RV has a greater geometrical complexity than the LV, and the RV free wall is heavily 
trabeculated making edge recognition difficult. Overlap between the RV and other cardiac chambers in some 
imaging modalities makes reliable volume measurement difficult (Gewillig et al., 2009). Compared to the LV, 
the RV is a thin walled structure under normal conditions. The normal RV is accustomed to a low pulmonary 
resistance and, hence, low afterload; thus, normal RV pressure is low and RV compliance high. The RV is 
therefore, sensitive to changes in afterload and alterations in RV size and function are indicators of increased 
pulmonary vascular resistance and load transmitted from the left sided chambers. Elevations in RV afterload 
are manifested acutely by RV dilatation and chronically by concentric RV hypertrophy (Lundstrom, 1974; 
Godfrey & Baum, 1979;). 
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2.3.2    POSTNATAL CIRCULATORY DEVELOPMENT 
 
An understanding of fetal hemodynamics and the acute and chronic changes that occur with transition to the 
newborn circulation are important for the care of normal newborns and are crucial to the recognition, 
diagnosis, and management of the newborn with significant congenital heart disease (Moss & Adams, 1968; 
Godfrey & Baum, 1979; Silverman, 1993; Goldenberg et al., 2008). 
 
 
a) Function 
 
The primary function of the circulatory system of both the fetus and newborn is to deliver nutrients 
to metabolizing organs. It also has to return deoxygenated blood to the lungs to replenish the oxygen 
and eliminate the waste product CO2. In the fetus, the organ responsible for gas exchange is the 
placenta, and its vascular connections are in a parallel arrangement with the other systemic organs, 
remote from the pulmonary circulation. In order to supply deoxygenated blood to the placenta and 
return oxygenated blood to the systemic organs, a series of extra cardiac shunts (ductus venosus, 
ductus arteriosus) and an intracardiac communication (foramen ovale) are necessary. Following 
birth, the function of gas exchange is transferred from the placenta to the lungs, and then from the 
systemic circulation to the pulmonary circulation. The venous and arterial circulations are separated, 
and not only are the fetal shunts unnecessary, but their persistence may lead to circulatory 
compromise (Moss & Adams, 1968; Godfrey & Baum, 1979; Larsen William, 2001). 
 
b) Circulatory Transition 
 
The transition from the fetal to the neonatal circulation includes the elimination of the placental 
circulation, lung expansion, and an increase in lung blood flow. In doing so, the entire cardiac output 
can be accommodated, and closure of the foramen ovale, ductus arteriosus, and ductus venosus can 
occur (Agata et al., 1991; Klabunde, 2005). 
 
Hyaline Membrane Disease (HMD), hypoxemia and acidemia keep the pulmonary pressures high but 
slightly lower than the aortic pressure. The hypoxemia also keeps the ductus arteriosus patent. 
Closure is dependent on the rise in Partial Pressure Oxygen pressure (PaO₂). The muscle in the 
ductus wall constricts when PaO₂ rises. Prostaglandin E, low calcium (Ca), low glucose and high 
pulmonary artery pressure all tend to keep the ductus patent open, whereas adrenaline and 
noradrenalin constrict it (Godfrey & Baum, 1979; Chesler, 1986; Klabunde, 2005). 
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For most structural congenital heart diseases, the fetal shunt pathways allow redistribution of 
ventricular blood flow so that systemic blood flow is adequate and fetal growth and development is 
therefore normal. With severe left heart obstruction, the burden of systemic and pulmonary blood 
flow is transferred to the fetal right ventricle, with reversal of blood flow at the foramen ovale, and 
systemic blood flow almost entirely transmitted via the ductus arteriosus. This "ductal-dependent" 
systemic circulation is poorly tolerated in the newborn, because normal closure of the ductus 
arteriosus progressively decreases systemic blood flow and progresses to circulatory failure and 
shock. Severe right heart obstruction is well tolerated in the fetus, because the combined fetal cardiac 
output can be transferred to the aorta, with the ductus arteriosus supplying predominantly lung 
blood flow. After birth, such "ductal-dependent" pulmonary blood flow can lead to critically low 
levels of pulmonary blood flow and severe cyanosis following constriction of the ductus arteriosus 
(Moss & Adams 1968; Chesler 1986; Moore 2006). 
 
c) Changes in Pulmonary Pressures 
 
Changes at birth in the infant’s vascular system are caused by the termination of placental blood flow 
and the onset of respiration. The ductus arteriosus closes by muscular contraction of its wall and the 
amount of blood flowing through the lung vessels increases rapidly. This in turn, raises the pressure 
in the left atrium. Simultaneously, pressure in the right atrium decreases as a result of interruption of 
placental blood flow. The septum primum is then pressed against the septum secundum and 
functionally the oval foramen closes. However, during the first days of life, especially in preterm 
infants, this closure is reversible. Since the newborn’s lungs aren’t fully developed, a series of 
pulmonary factors also influences the circulatory system (Godfrey & Baum, 1979; Agata et al., 1991; 
Moore, 2006). 
 
The mean pulmonary artery pressure in the infant falls from fetal levels of  
40–80 mmHg to values between 20-50 mmHg at 6-8h and to 20-35 mmHg at 36h after birth. The 
pressure usually reaches a level close to that of the adult within 2 weeks of birth but continues to fall 
slightly more until 6 weeks of age (Godfrey & Baum, 1979; Chesler, 1986). 
 
Decreased alveolar ventilation results in ventilation: perfusion mismatch and pulmonary arteriolar 
vasoconstriction.  Pulmonary vasoconstriction can lead to an increase in right heart volume and 
pressure, resulting in a shunting of blood back from the right atrium through the patent foramen 
ovale of the newborn, and directly into the left atrium. Likewise, high pulmonary vascular resistance 
can result in deoxygenated blood bypassing the lungs and being delivered directly to the systemic 
circulation, via the ductus arteriosus.  Crying by the baby creates a shunt from right to left, which 
accounts for cyanotic episodes in the newborn (Chesler, 1986; Agata et al., 1991; Klabunde, 2005). 
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d) Respiration 
 
When respiration begins at birth, most of the lung fluid is rapidly absorbed by the blood and lymph 
capillaries, and expelled via the trachea and bronchi during delivery. When the fluid is reabsorbed 
from the alveolar sac, surfactant remains deposited as a thin phospholipid coating on the alveolar 
membranes. With air entering alveoli during the first breath, the surfactant coating prevents 
development of an air-water interface with high surface tension. Surfactant is particularly important 
to the survival of the premature infant. When surfactant is insufficient the air water (blood) surface 
membrane tension becomes high, creating the risk that alveoli will collapse during expiration. As a 
result, respiratory distress syndrome (RDS) develops. The more premature the infant, the more likely 
RDS will develop due to HMD (Chesler, 1986; Moore, 2006). 
 
RDS which is also known as HMD accounts for approximately 20% of deaths among newborns (Moss 
et al., 1968; Moore, 2006). Infants with RDS and ventilatory insufficiency have elevated levels of 
Partial Pressure Carbon dioxide (PaCO2) and a low pH. The enzymatic pathways for lecithin synthesis 
are sensitive to cold, hypoxia and acidemia. Post natal exposure to temperatures less than 35˚C and a 
pH less than 7.25 causes a rapid fall in the amount of surfactant detectable in the pharyngeal 
aspirates, thus decreasing the rate of synthesis of surfactant in an in vitro lung system by 50% (Moss 
& Adams, 1968; Moore, 2006). 
 
Importantly, type II alveolar cells that produce surfactant do not mature until between 28 and 32 
weeks gestation. The total number of premature alveoli in the full term infant is only 8% of the full 
adult complement; therefore any infant born before surfactant is present in the alveoli encounters 
high alveolar surface tension with each breath. This elevated blood pressure in the pulmonary 
vascular systems may be due to serious respiratory or cardiovascular disease. Premature infants 
have weak immature chest muscles making it almost impossible for an infant without surfactant to 
successfully expand the alveoli (Godfrey & Baum, 1979; Chesler, 1986; Agata et al., 1991; Klabunde, 
2005). 
 
The pulmonary circulation is usually a low pressure, low resistance circulation (Agata et al., 1991; 
Larsen, 2001). Therefore, according to Chesler (1986) the main reasons why pulmonary 
hypertension occurs are: 
 
(a) Prolonged increase in pulmonary blood flow PDA; left to right shunt. 
(b) Increase in pulmonary resistance to flow. 
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(c) Vasoconstriction (narrowing of the blood vessels resulting from contraction of the muscular 
wall of the vessels, particularly the large arteries, small arterioles and veins). 
 
When the heart is unable to meet the oxygen and nutrient demands of the body, heart failure can 
result from either diastolic or systolic dysfunction. When the right ventricle must pump continually 
against a very high afterload (increased resistance), vascular musculature cells hypertrophies and 
become stiff.  Stiffness of the muscle cells causes a reduction in ventricular compliance, leading to a 
decrease in stroke volume. Right ventricular end diastolic relaxation and right ventricular end 
diastolic pressure are elevated and reflected back into the venous system. Because stroke volume and 
hence blood pressure fall, baro-receptor reflexes are activated (Godfrey & Baum, 1979; Klabunde, 
2005; Moore, 2006). 
 
Ultimately, longstanding pulmonary hypertension would cause the right ventricle to fail and long 
standing systemic hypertension would cause the left ventricle to fail (Godfrey & Baum, 1979; Chesler, 
1986). 
2.3.2.1 THE UPSTREAM EFFECTS OF RIGHT HEART FAILURE 
 
 Decreased pulmonary flow 
 Decreased blood oxygenation 
 Fatigue 
 Decreased systemic blood pressure due to decreased left heart filling (Moss & Adams, 1968; 
Klabunde, 2005). 
2.3.2.2 THE DOWNSTREAM EFFECTS OF RIGHT HEART FAILURE 
 
Echocardiography is useful in assessing the underlying cause and severity of pulmonary hypertension. The 
echocardiographic features of pulmonary hypertension (PHT) are seen on a 2-Dimensional Echocardiography 
and are listed below: 
 
a) Dilated Pulmonary artery (normally the pulmonary artery diameter should not be greater than the 
aortic diameter). 
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b) Right ventricle dilatation and/or hypertrophy. 
c) Right atrium dilatation. 
d) Abnormal interventricular septum motion. 
e) Measuring Pulmonary artery systolic pressure using tricuspid regurgitation velocity. 
 
The normal newborn elektrocardiogram (ECG) would be interpreted as showing right ventricular 
hypertrophy, this effect is even more pronounced in premature infants, since the ECG reflects predominantly 
the weight of the cardiac chambers. Following birth, the relative weight of the right to the left ventricle falls to 
its adult value of 40% at around 9 months of age (Godfrey & Baum, 1979). 
2.3.3    DIFFERENCES IN INFANT CIRCULATION: PRE T ERM VERSUS FULL 
TERM   
 
The cardiac muscle is immature at birth and heart rate is an important determinant of cardiac output 
(Godfrey & Baum, 1979). Cardiac output in neonates is high due to high sympathetic tone, especially around 
the times of birth, and this also explains the high resting heart rate of neonates. By comparing fetal with adult 
sheep moderator bands or papillary muscles, it has been demonstrated that fetal and neonatal myocardial 
strips have higher resting tension and lower developed active tension during isometric contraction. This is 
probably due to the lower proportion of sarcomeres, which is about half of that in the adult (Godfrey & Baum, 
1979). Therefore heart rate is an important determinant of cardiac output, if the heart beats faster; there is 
less filling time, and thus less cardiac output. 
 
Fetal sarcomeres are randomly arranged compared to the parallel arrangement in the adult. The reduction in 
fetal myocardial contractility is reflected in experiments. However, neonatal cardiac muscle is much less 
susceptible to anoxia than mature muscle. This probably reflects a greater ability to metabolize anaerobically. 
There are differences between fetal, neonatal, and adult ventricles. Distensibility though these differences 
may depend upon the definition of distensibility employed (Godfrey & Baum, 1979), but in general, the fetal 
heart is less compliant. 
 
Afterload is also a major determinant of cardiac output. The neonatal heart is exquisitely sensitive to 
increases in systemic or pulmonary vascular resistance which will reduce the cardiac output. The 
myocardium is dependent on extracellular calcium for contraction and ionized hypocalcaemia is poorly 
tolerated. These effects are amplified in the heart of the premature infant (Godfrey & Baum, 1979). 
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Fetal haemoglobin is the main oxygen transport protein in the fetus during the last seven months of 
development in the uterus and in the newborn until roughly 6 months old. Functionally, fetal haemoglobin 
differs from adult haemoglobin in that it is able to bind oxygen with greater affinity than the adult form, 
giving the developing fetus better access to oxygen from the mother’s bloodstream. Its oxygen dissociation 
curve is shifted to the left, meaning that it will take up oxygen at a lower concentration than adult 
haemoglobin will. This enables fetal haemoglobin to absorb oxygen from adult haemoglobin in the placenta, 
which has a lower oxygen pressure than the lungs (Chesler, 1986; Larsen, 2001). 
2.3.4    INTRAUTERINE GROWTH RETARDATION (IUGR)  
 
When fetal size is less than expected, the condition is known as intrauterine growth retardation (IUGR) also 
called fetal growth restriction (FGR). These babies are small for gestational age (Steer, 2005) and defined as 
babies whose birth weight lies below the 10th percentile for a specific gestational age (Goldenberg et al., 
2008). 
IUGR causes both perinatal and neonatal medical complications. Both epidemiological and experimental 
evidence suggest that IUGR contributes to a wide array of metabolic disorders and chronic diseases in adult 
life (Steer, 2005). 
 
Low birth weight (LBW) is sometimes incorrectly used synonymously with SGA, defined as a fetus that 
weighs less than 1000g regardless of gestational age (Sadler, 2006). 
CAUSATIVE FACTORS INCLUDE: 
 
 Chromosomal abnormalities (10%). 
 Teratogens. 
 Congenital infections (rubella, cytomegalovirus, toxoplasmosis, and syphilis). 
 Poor maternal health (hypertension and renal and cardiac disease). 
 The mother’s nutritional status and socioeconomic level. 
 Maternal use of cigarettes, alcohol, and other drugs. 
 Placental insufficiency and multiple births (e.g. twins, triplets) Sadler, 2006). 
 
One third of babies born with a low birth weight are also small for gestational age. Whether the cardiac size of 
small for gestational age (SGA) fetuses is smaller or larger than appropriate for gestational age (AGA) 
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foetuses remains unanswered. Ultrasonic studies have reported that the cardiac dimensions for SGA foetuses 
can be smaller or greater than AGA infants but are not significantly different (Goldenberg et al., 2008). 
 
Fetal growth restriction has the potential to be associated with both growth restriction and enlarged hearts. 
Two different pathways may account for cardiomegaly in SGA foetuses. Firstly, increased resistance in the 
systemic and placental circulation typical of fetal growth restriction may lead to an increase in afterload. This 
over time could result in compensatory myocardial hypertrophy. Ream and co-workers (2008) observed that 
the cardiomegaly associated with fetal growth restriction was due to hypertrophy of the myocardial free wall. 
Secondly, longstanding hypoxemia, possibly compounded by an increased oxygen demand of the 
hypertrophic fetal heart, may lead to cardiac dysfunction and cardiac failure, with a consequent increase of 
cardiac dimensions in relation to body weight. Hypoxia is frequently present in SGA foetuses and fetal growth 
restriction is considered one of the mechanisms by which the fetus adapts to hypoxia (Ream et al., 2008). 
 
Infants with congenital heart disease are approximately twice as likely to be small for gestational age and this 
may affect clinical management decisions, therapeutic response and prognosis of these neonates (Ream et al., 
2008). 
2.3.5     FACTORS AFFECTING FETAL GROWTH 
 
There are a number of factors that have an effect on fetal growth and some of these include: 
2.3.5.1 MATERNAL FACTORS LEADING TO PLACENTAL INSUFFICIENCY 
 
(a) Maternal weight 
 
Maternal weight plays an important role since obesity increases the risk of medically – indicated 
preterm birth and very early spontaneous preterm birth. On the other hand being underweight also 
increases the risk of both preterm birth subtypes (Guayao, Fuller, Bazer, Timothy, Cudd, Cynthia, 
Menininge & Spencer, 2004). 
 
(b) Maternal age 
 
The mother’s age seems to play an important role in optimal fetal growth. If the mother is under the 
age of 18 or older than 35 the risk of impaired fetal growth escalates (Krupa et al., 1994). 
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(c) Nutritional status 
 
The nutritional status of the mother is important for fetal development and a diet low in saturated fat 
and cholesterol may help reduce the risk of a preterm delivery. Nutrition is the major intrauterine 
environmental factor that alters expression of the fetal genome and may have lifelong consequences. 
Alterations in fetal nutrition and endocrine status may result in developmental adaptations that 
permanently change the structure, physiology, and metabolism of the offspring, thereby predisposing 
individuals to metabolic, endocrine, and cardiovascular disease in adult life (Guayao et al., 2004). 
 
Impaired placental synthesis of nitric oxide, a major vasodilator and angiogenesis factor and 
polyamines (key regulator of DNA and protein synthesis) may provide a unified explanation for 
intrauterine growth retardation in response to the two extremes of nutritional problems with the 
same pregnancy outcome. Maternal malnutrition during gestation reduces placental and fetal growth. 
Evidence suggests that fetal growth is most vulnerable to maternal dietary deficiencies peri-
implantation, during the period of rapid placental development (Guayao et al., 2004). However, 
maternal over nutrition can retard placental and fetal growth, and may result in fetal growth 
restriction and increased risk of neonatal mortality and morbidity. 
 
(d) Substance abuse 
 
Toxin exposure (tobacco, alcohol, heroin, and other drugs which can also harm the fetus in other 
ways) contributes significantly to low birth weight. Chronic increased resistance in the uterine, 
umbilical and fetal cerebral arteries are associated with mothers that smoke (Albuquergue, Smith, 
Johnson, Chao & Harding, 2004). 
 
(e) Diabetes 
 
Maternal diabetes (disturbances in carbohydrate metabolism during pregnancy) causes a high 
incidence of still births, neonatal deaths, abnormally large infants, and congenital malformations. The 
risk of congenital anomalies in children of diabetic mothers is 3-4 times that for the offspring of non-
diabetic mothers (Krupa et al., 1994; Goldenberg et al., 2008). 
 
(f) Anatomy of the Uterus 
 
Abnormal uterine/cervix cavity for example a short cervix, or the stretching of the uterus or over 
distension of the uterus, has also been linked to preterm labor and birth. This can be caused by 
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fibroids, multiple pregnancies (twins, triplets, etc), or even having too much amniotic fluid 
(polyhydramnios). Woman who has tried to conceive for more than a year before getting pregnant is 
at a 40% higher risk for premature birth (Krupa et al., 1994). 
2.3.5.2    FETAL AND PLACENTAL FACTORS 
 
As the fetus increases in size, its nutritional demands increase, causing major changes in the placenta. 
Foremost is an increase in surface area between the maternal and fetal components to facilitate exchange. 
The disposition of fetal membranes is also altered as production of amniotic fluid increases. 
 
As a result of the continuous growth of the fetus and expansion of the uterus, the placenta also enlarges. Its 
increase in surface area roughly parallels that of the expanding uterus, and throughout pregnancy it covers 
approximately 15% to 30% of the internal surface of the uterus (Sadler, 2006). 
 
The exchange of metabolic and gaseous products between the maternal and fetal bloodstream, such as O2, 
CO2, and carbon monoxide is accomplished by simple diffusion. At term the fetus extracts  
20-30ml of oxygen per minute from the maternal circulation, and even a short term interruption of the 
oxygen supply is fatal to the fetus. Placental blood flow is critical to oxygen supply, since the amount of 
oxygen reaching the fetus primarily depends on delivery, not diffusion (Sadler, 2006). 
 
Exchange of nutrients and electrolytes, such as amino acids, free fatty acids, carbohydrates and vitamins, is 
rapid and increases as pregnancy advances. By the end of the forth month, the placenta produces 
progesterone in sufficient amounts to maintain pregnancy if the corpus luteum is removed or fails to function 
properly. In addition to progesterone, the placenta produces increasing amounts of estrogenic hormones 
predominantly estriol, until just before the end of pregnancy. These high levels of estrogens stimulate uterine 
growth and development of the mammary glands. Another hormone produced by the placenta is 
somatommamotropin. It is a growth hormone like substance that gives the fetus priority on maternal blood 
glucose and makes the mother somewhat diabetogenic and it also promotes breast development for milk 
production (Sadler, 2006). 
 
2.3.5.2.1 Fetal factors 
 
(a) Fetal hypoxia 
 
Fetal hypoxia causes intrauterine growth restriction and low birth weight, and is associated with 
prematurity, infant mortality and elevated risk of adult cardiovascular disease. High altitude hypoxia 
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is thought to be responsible for the 100g decrease in birth weight associated with each 1,000 meter 
increase in elevation of maternal residence.  Hypoxia severely compromises the cardiovascular 
system. Hypoxia induces ventricular dilation and myocardial hypoplasia, decreasing ventricular 
tissue by 50% (Ream et al., 2008). 
 
(b) Drugs 
 
The use of antenatal steroids has largely demonstrated its effectiveness in reducing the incidence of 
respiratory distress syndrome (RDS). Meta analysis of the clinical trials performed has confirmed its 
effectiveness when administered to the mother one week before delivery to reduce neonatal 
mortality, incidence and severity of bronchopulmonary dysplasie (BPD), intracranial haemorrhage 
(ICH), retinopathy of prematurity (ROP) and necrotizing enterocolitis (NEC)(Krupa et al., 1994). 
 
Dexamethazone is often administered to preterm babies during the early neonatal period in order to 
prevent chronic lung disease and this is known to produce hypertrophy of the left ventricle (Moss & 
Adams, 1968; Silverman, 1993). 
 
2.3.5.2.2 Placental factors 
 
(a) Perinatal Asphyxia 
 
Perinatal asphyxia, (a rare condition in premature infants) is a medical condition resulting from 
deprivation of oxygen (hypoxia) to an infant for a long enough period to cause apparent harm. It 
commonly results from a drop in maternal blood pressure or interference with blood flow to the 
infant's brain. This may occur due to inadequate circulation or perfusion, impaired respiratory effort, 
or inadequate ventilation. Perinatal asphyxia happens in 2 to 10 per 1000 newborns that are born at 
term (Krupa et al., 2006). An infant suffering severe perinatal asphyxia usually has cyanosis, 
accompanied by poor perfusion, responsiveness, muscle tone, and respiratory effort, as reflected in a 
low 5 minute Apgar score. A bad degree of asphyxia can lead to cardiac arrest and ultimately death. 
Hypoxic damage can affect the infant's heart, but brain damage is of most concern for it is least likely 
to heal completely (Krupa et al., 2006). 
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2.4 ECHOCARDIOGRAPHY 
2.4.1    DEFINITION 
 
Also known as a cardiac ultrasound, echocardiography uses standard ultrasound techniques to image two-
dimensional slices of the heart, currently 3D real-time imaging is also available (Silverman, 1993; Otto, 2004; 
Feigenbaum, Armstrong & Ryan, 2005). 
 
Evaluation of ventricular systolic function is the most important application of echocardiography, so that 
even when evaluation of systolic function is not the focus of the examination, it plays an essential role in 
every study (Otto, 2004). 
 
In addition to creating two-dimensional pictures of the cardiovascular system, it can also produce accurate 
assessment of blood velocity and cardiac tissue at any arbitrary point using pulsed or continuous wave 
Doppler ultrasound (Silverman, 1993). 
 
This allows for the assessment of cardiac valve areas and function, abnormal communications between the 
left and right side of the heart, leakage of blood through the valves, and the calculation of cardiac output and 
ejection fraction (Silverman 1993; Feigenbaum et al., 2005). 
 
Echocardiography has been available for the evaluation of cardiac abnormality and function for over 20 years. 
In fact, it is the most widely used diagnostic test for heart disease and can provide a wealth of helpful 
information. By assessing the motion of the heart wall echocardiography can help detect the presence and 
assess the severity of cardiac disease (Silverman, 1993; Otto 2004; Feigenbaum et al., 2005). 
2.4.2    APPLICATION OF ECHOCARDIOGRAPHY 
 
During a routine echocardiography examination, a transducer (or probe) is placed on the chest wall (or 
thorax) of the subject, and images are taken through the chest wall. This is a non-invasive, highly accurate and 
quick assessment of the overall health of the heart. When properly applied, the diagnostic and prognostic 
utility of echocardiography, are unmatched. Images are displayed on a monitor, and recorded either by 
videotape or by digital techniques (Silverman, 1993; Otto, 2004; Feigenbaum et al., 2005). 
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2.4.3    ADVANTAGES OF ECHOCA RDIOGRAPHY 
 
Echocardiography has a major advantage when assessing fragile, unstable premature or low birth weight 
infants for it is a non-invasive, easy to use procedure with no known risks or side effects (Silverman, 1993; 
Feigenbaum et al., 2005). Linear measurements from M-Mode and 2D images have proven to be reproducible 
with low intra-observer and inter-observer variability (Lang, Bierig, Devereux, Flachskampf, Foster, Pellikka, 
Picard, Roman, Seward, Shanewise, Solomon, Spencer, Sutton & Stewart, 2005). 
2.4.4    DISADVANTAGES OF ECHOCARDIOGRAPHY  
 
Reference ranges for cardiac measurement are available for adults, children and term infants. However, these 
have not been updated in line with improvements in scanning or extended to include the large numbers of 
extremely small, premature infants surviving as a result of modern intensive care. Normal values of blood 
flow velocities for these infants are even less well studied (Silverman, 1993; Otto, 2004; Feigenbaum et al., 
2005). 
2.4.5     CALCULATIONS OBTAINED FROM ECHOCARDIOGRA PHY  
2.4.5.1    M-MODE 
 
2.4.5.1.1 Definition 
 
M-mode is a two-dimensional motion mode echocardiographic view of the heart (Silverman, 1993; 
Otto, 2004; Feigenbaum et al., 2005). 
 
2.4.5.1.2 Application of M-Mode 
 
By definition, M-mode assessment provides information regarding the size and contractility of the 
heart along a single line (Silverman, 1993; Otto, 2004; Feigenbaum et al., 2005). 
2.4.5.1.3   INFORMATION OBTAINED FROM M-MODE EXAMINATION 
 
 Motion and time which is displayed on the horizontal axis. 
 Distance and depth which is displayed on the vertical axis. 
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2.4.5.1.4 Advantages of M-Mode 
 
The advantage of M-mode echocardiography is the simplicity of measurement.  Its high frame rates 
guarantee superior time resolution.  The dimensions of the cardiac chambers, walls and valve leaflets 
can be easily traced, providing a rapid, accurate and repeatable method for assessing and measuring 
any changes that occur with growth and development (Silverman, 1993; Otto, 2004; Feigenbaum et 
al., 2005). 
 
Particularly in the paediatric population where segmental wall motion abnormalities are rare, M-
mode values are a good estimate of Left Ventricle performance (Table 2.2; Silverman, 1993; Otto, 
2004; Feigenbaum et al., 2005). 
 
There are also numerous measurements and calculations that can provide indirect evidence of 
hemodynamic severity of cardiac lesions, and M-mode echocardiography is also able to identify the 
secondary consequences of the primary hemodynamic pathology (Table 2.1; Silverman, 1993; Otto, 
2004; Feigenbaum et al., 2005). 
TABLE 2.1 M-MODE ECHOCARDIOGRAPHIC MEASUREMENTS (adapted from 
Feigenbaum et al., 2005; Otto, 2004; Silverman, 1993) 
Cardiac chamber dimensions 
 Aorta and left atrium 
 Left ventricle 
 Right ventricle 
Left ventricular systolic function 
 Fractional shortening 
 Ejection fraction 
 Stroke volume and cardiac output 
 Systolic time intervals of the aortic valve 
 Mitral E point septal separation 
Left ventricle mass  American Society of Echocardiography (ASE) method 
Hemodynamic abnormalities 
pulmonary hypertension 
 Absent or diminished pulmonary A wave 
 Mid systolic closure or notching of the pulmonary valve 
 Alterations in right ventricle systolic time intervals 
 D-shaped left ventricle  
Increased right atrial pressure 
 Dilated Inferior Vena Cava with lack of  collapse 
 Bowing of interatrial septum toward the left atrium 
Increased left atrial pressure  Bowing of interatrial septum towards the right atrium 
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2.4.5.1.5 Disadvantages of M-Mode  
 
As mentioned before, M-mode assessment provides information regarding the heart’s size and 
contractility along a single line (Silverman, 1993; Otto, 2004; Feigenbaum et al., 2005). 
This may either underestimate the severity of dysfunction if only a normal region is interrogated or 
can overestimate an abnormality if the M-Mode beam transits exclusively through the wall motion 
abnormality. Thus, although conceptually simple, M-mode derived linear measurements have the 
disadvantage of only determining ventricular function along a single interrogation line. In presence of 
normal geometry and symmetric function, linear measurements provide an adequate assessment of 
ventricular function. However, they are limited, in acquired heart disease, in which there may be 
substantial regional variation in function, and are subjected to error with respect to determining true 
minor–axis dimensions. Two–dimensional imaging allows correction for off-axis heterogeneity of 
function (Silverman, 1993; Otto, 2004; Feigenbaum et al., 2005). 
 
Available results from other studies on intra-observer and inter-observer variations of 
echocardiographic measurements are limited. Previous studies on inter-observer variation of 
echocardiographic measurements have shown different results.  Most studies varies within the limits 
of 10% (Shifan, Ayres, Harris, Bricker & Labarthe, 1999; Sahn, DeMaria, Kisslo & Weyman, 1987). 
 
TABLE 2.2 CARDIAC STRUCTURES AND DETECTABLE ABNORMALITIES (adapted 
from Feigenbaum et al., 2005; Otto, 2004; Silverman, 1993) 
CARDIAC STRUCTURE DETECTABLE ABNORMALITIES 
Aortic Root 
 Dilatation 
 Dissection flaps 
 Ascending aorta aneurysms 
 Sinus of Valsalva aneurysm 
 Supravalvular stenosis 
Aortic valve 
 Reduced leaflet excursion: valvular stenosis or reduced 
cardiac output 
 Calcification 
 Prolapse 
 Vegetations 
 Bicuspid valve 
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 Systolic doming 
 Premature aortic valve closure 
Left atrium 
 Dilatation 
 Thrombus 
 Myxomas 
 Cor triatriatum 
  
 
Mitral valve and supporting 
structures 
 Reduced mobility, valvular stenosis or reduced cardiac 
output 
 Valvular or annulus calcification 
 Prolapse 
 Ruptured chordae 
 Failure of leaflet coaptation 
 Vegetations 
 Diastolic mitral valve flutter 
 Systolic anterior motion of the mitral leaflet 
Left ventricular outflow tract 
 Outflow obstruction, muscular or membranous or due to 
systolic anterior motion of the anterior mitral leaflet 
Aorta-septal and Mitral- Aortic 
Continuity 
 Discontinuity as seen in certain congenital heart lesions 
Interventricular septum 
 Increased thickness or hypertrophy 
 Thinning associated with myocardial infarction 
 Reduced systolic thickening 
 Hypokinesia or akinesia associated with ischemic heart 
disease 
 Abnormal motion due to ischemia or infarction. Left bundle 
branch block, pacemaker rhythm, post open heart surgery, 
volume or pressure overload right ventricle 
Inferolateral wall 
 Increased thickness or hypertrophy 
 Thinning: associated with myocardial infarction 
 Aneurysm or pseudo aneurysm 
 Reduced systolic thickening 
 Hypokinesia or akinesia: associated with ischemic heart 
disease 
 
Left ventricle cavity 
 Dilatation 
 Systolic dysfunction 
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 Thrombus 
 Intracavity masses or tumors 
Right ventricle cavity 
 Dilatation 
 Impaired systolic function 
 Increased right ventricular thickness 
Coronary sinus 
 Dilatation: most commonly associated with a persistent left 
superior vena cava 
Descending aorta 
 Dilatation 
 Aortic dissection flaps 
 Differentiation between pleural and pericardial effusions 
Right atrium 
 Dilatation 
 Intracardiac masses/tumours 
Tricuspid valve 
 Reduced mobility: valvular stenosis or reduced cardiac 
output 
 Systolic doming 
 Prolapse 
 Ruptured chordae 
 Vegetations 
Right ventricle outflow tract 
 Dilatation 
 Infundibular narrowing 
 Increased free wall thickness 
Pulmonary valve 
 Stenosis 
 Prolapse 
 Vegetations 
 Dysplasia 
Pulmonary artery 
 Dilatation 
 Supra valvular stenosis 
 Branch of peripheral pulmonary artery narrowing or 
stenosis 
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2.4.5.2    LEFT VENTRICULAR FUNCTION (LVF) 
 
Left Ventricular systolic function is a major prognostic factor in cardiac disease and has important 
implications for treatment. Left Ventricular systolic function can be assessed by M- mode, 2-D and Doppler 
techniques (Silverman, 1993; Otto, 2004; Feigenbaum et al., 2005). 
 
2.4.5.2.1 Left Ventricle Wall Dimensions 
 
This measurement determines the thickness of the left ventricle of the heart. It can be used as the global index 
of systolic function and one of the most commonly used markers of systolic function (Silverman, 1993; Otto, 
2004; Feigenbaum et al., 2005). 
 
2.4.5.2.2 Systolic Function 
 
Left Ventricle internal dimension measurements in end-systole (LVESD) and end-diastole (LVEDD) are 
measured at the level of the mitral valve leaflet tips in the parasternal long axis view. LVEDD is at the end of 
diastole, and LVESD is at the end of systole. The LVEDD and LVESD measurements can be used to calculate LV 
fractional shortening, LV ejection fraction and LV volume, which give some indication of LV systolic function 
(Silverman, 1993; Otto, 2004; Feigenbaum et al., 2005). 
 
The ejection fraction (EF) is the percentage change in left ventricle volume between systole and diastole: 
EF= (LVEDD)3 – (LVESD)3/ (LVEDD)3 X 100% 
Normal range of EF is 50-58% (Silverman, 1993). 
 
2.4.5.2.3 Shortening fraction (SF) 
 
Shortening fraction (SF) is commonly used and is the percentage of change in LV internal dimensions (not 
volumes) between systole and diastole: 
SF = LVEDD-LVESD/LVEDD X 100%  
 
The shortening fraction is a slightly different way of measuring left ventricular performance. Instead of 
measuring and rationing blood volumes, the shortening fraction measures and ratios the change in the 
diameter of the left ventricle between the contracted and relaxed states (Silverman 1993).  
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The normal range is 0.18-0.42%, or 18-42%, above 30% is considered normal, with 26-30% representing a 
mild decrease in function (Silverman, 1993; Otto, 2004; Feigenbaum et al., 2005). 
 
2.4.5.2.3.1 Advantage of Shortening Fraction (SF) in Premature Infants 
 
The shortening fraction is most often used to determine left ventricular function. Since it is relatively 
independent of changes in heart rate as seen with age, or loading conditions of the heart, it is thus 
independent of pre-load/afterload (Silverman, 1993; Otto, 2004; Feigenbaum et al., 2005). 
2.4.6     CALCULATIONS OBTAINED FROM DOPPLER ECHOC ARDIOGRAPHY 
MYOCARDIAL PERFORMANCE INDEX (MPI) 
 
2.4.6.1.1 Definition 
 
Myocardial performance index (MPI) is a non-invasive, quantitative, Doppler-based measurement of global 
cardiac function, which integrates systolic and diastolic function (Tei, Ling, Hodge, Bailey, Oh, Rodeheffer, 
Tajik & Seward, 1995). 
 
MPI is a ratio derived from the sum of isovolumic contraction time and isovolumic relaxation time divided by 
left ventricle ejection time. The normal value for this parameter is 0.39 ± 0.05 (Tei et al., 1995). 
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Figure 2.1 Method used to calculate MPI (adapted from Tei et al., 1995). 
 
2.4.6.1.2 Application and Importance of MPI 
 
The method used for calculating left ventricular index of myocardial performance, defined as (a-b)/b, where 
a, is the interval between cessation and onset of mitral inflow, and b is ejection time (ET) of LV outflow. 
Isovolumic relaxation time (IRT) is measured by subtracting interval c between R wave and onset of mitral 
flow. Isovolmetric contraction time (ICT) is obtained by subtracting IRT from (a-b) (Figure 2.1; Tei et al., 
1995). 
 
Patients with congestive heart failure, and signs and symptoms of heart failure have been associated with 
isolated diastolic dysfunction (Tei et al., 1995) the prevalence and annual mortality differ from those with 
other forms of heart failure. Published criteria for diastolic heart failure includes the presence of signs or 
symptoms of heart failure, evidence of abnormal relaxation or filling, and an ejection fraction of at least 45%. 
However a single measurement of an ejection fraction ≥45% seems inappropriate to exclude the presence of 
mild or moderate impairment of systolic function (Tei et al., 1995). 
 
The myocardial performance index has been used as a combined systolic-diastolic index and is prognostic for 
patients with dilated cardiomyopathy (Harada, Tamura, Toyono & Yasuoka, 2002). 
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2.4.6.1.3 Advantages of the MPI 
 
MPI index is easy to perform, reproducible, and independent of heart rate and blood pressure, and is 
relatively independent of age. In adults, the MPI correlates well with invasive measurements of left 
ventricular systolic and diastolic function (Tei et al., 1995). It is also a sensitive indicator of generalized 
cardiac dysfunction in patients with mild to moderate congestive heart failure. MPI is particularly useful in 
congenital heart disease, where the anatomy is not suitable for conventional methods to assess ventricular 
function (Eto, Ishii, Tei, Tsutsumi, Akagi & Kato, 1999). 
 
2.4.6.1.4 Disadvantages of MPI 
 
Systematic evaluation of this index in the normal and abnormal left ventricle has not been performed in 
experimental preparations. This is specifically important with regard to the influence of heart rate, preload 
and afterload alterations. Research has been limited to assessing the effect of resting heart rate or arterial 
pressure on index of myocardial performance in groups with normal and abnormal function (Tei et al., 1995; 
Bruch, Schemermund, Marin, Bartel, Schaar & Erbel, 2000). 
 
Normal values for the MPI index have been determined for adults and are in the process of being developed 
for children. A need to determine normal values for premature neonates thus unmistakably exists. 
2.5 PUBLISHED ECHOCARDIOGRAPHIC REFERENCE VALUES 
 
Nearly all published normal reference ranges, are either data from the start of routine echocardiography in 
the USA (mid 1970 to mid 1980) or consists of small and heterogeneous samples (Skelton et al., 1998). The 
largest paediatric cohort consisted of 205 healthy children. The wide range of change during the normal 
development of the cardiac structure requires a large study group for accurate data on normal values 
(Skelton et al., 1998). In the last 15-20 years there have been dramatic improvements in echocardiography.  It 
is now possible to obtain direct digital measurements and can be extended to include large numbers of 
extremely small, premature infants. 
 
There was considerable variation in the values for the reference limits reported by various studies (Roge et 
al., 1978; Walther et al., 1986; Skelton et al., 1998). A few studies had small sample sizes, although, the 
majority had modest though not ideal sample sizes (120 to 200 participants). Only 3 studies were based on 
large sample sizes (Roge et al., 1978; Walther et al., 1986; Skelton et al., 1998).  Besides the variation in 
sample sizes, differences in selection criteria and measurement techniques (2-D vs. M-mode) may have 
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contributed to the variability of reference limits. The contribution of differences in statistical analyses to this 
heterogeneity in reference values was difficult to ascertain. Generally, the descriptions of the statistical 
methods (parametric vs. nonparametric methods and the transformation of data) used for developing the 
reference limits in the studies were brief, and descriptions of the handling of outliers and the distribution of 
the data (caucasian vs. non-caucasian) were frequently lacking (Roge et al., 1978). 
2.5.1    PARTITIONING  
 
When developing cut-off points that separate "pathology" from "healthy", echocardiographers one must 
consider which covariates  is appropriate to refer to, because echocardiographic dimensions vary according 
to characteristics such as sex, age, and gender (Roge et al., 1978; Walther et al., 1986). 
2.5.2    AGE 
 
In the field of echocardiography, it is necessary to account for the impact of age in the paediatric age groups, 
given the continuing postnatal growth (Roge et al., 1978; Skelton et al., 1998). 
2.5.3    INDEXATION/ADJUSTMENT 
 
Because cardiac dimensions vary with body size, it would seem reasonable to interpret echocardiographic 
measurements in the context of the body size of an individual. Adjusting or indexing by body surface area 
("traditional" method) has been criticized because it "forgives" obesity-related variations in 
echocardiographic dimensions and has theoretic and mathematic limitations.  Height indexation (height 
raised to an appropriate power) has been used by some investigators because of several advantages. Height is 
easy to measure, is a "non-derived" variable, and is not subject to change during illness (Roge et al., 1978; 
Skelton et al., 1998). 
2.5.4    DEVIATION FROM REFERENCE VALUES 
  
Cardiologists frequently use the terms "mild," "moderate," and "severe" to describe the degree of abnormality 
of cardiac structures. Such a description of echocardiographic observations in relation to their deviation from 
reference limits enables the clinician to interpret the degree of abnormality. With the emphasis on primary 
care and the explosion of imaging modalities, non-specialist physicians and allied health care professionals 
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are increasingly required to order and interpret the resultant echocardiographic reports. Because it is 
virtually impossible for a non-specialist to keep track of various reference limits, such interpretative 
reporting of echocardiographic measurements is useful for the treating clinician. It has been suggested that 
values exceeding reference limits be divided empirically into categories based on the number of standard 
deviations above the reference limits. Another classification scheme categorizes echocardiographic 
measurements exceeding reference limits (formulated from a healthy reference sample) on the basis of 
percentile values (i.e., 95th, 98th, and 99th percentiles) derived in a larger community-based sample, which 
included people with prevalent disease. The validation of these approaches merits further exploration. 
Skelton and co-workers (1998) conducted a study consisting of 79 infants of less than 34 weeks gestation. 
Echocardiography was done on days 0,7 and 28 after birth to produce a set of reference ranges. Cardiac 
dimensions correlated well with gestation and birth weight. However, they found a close correlation between 
both gestation and birth weight for all physical measurements. 
 
Walther and colleagues (1986) investigated normative data on intracardiac dimensions and systolic time 
intervals in very low birth weight infants. M-mode echocardiograms were collected from 210 healthy preterm 
and term neonates with birth weights between 780 and 5,350g and gestational ages ranging from 26 to 43 
weeks. Fifty-nine neonates were less than 24h, 62 were between 25-48h, and 89 were between 48-144h of 
age. Diastolic and systolic left ventricular dimensions increased gradually with advancing birth weight (r = 
+0.84 and 0.78). Left atrial and aortic root dimensions tended to show a parabolic relationship with birth 
weight, increments were reduced at higher birth weights (r = +0.92 and 0.85). The shortening fraction of the 
left ventricle (mean +/- SD 33.8 +/- 4.9%) and the left atrial/aortic ratio (1.16 +/- 0.10) were constant 
throughout all weight subgroups. Pre-ejection periods and ejection times of both ventricles were reduced in 
preterm infants due to their higher heart rates, but left and right ventricular PEP/ET ratios in preterm and 
term infants were comparable. Septal thickness in diastole and in systole tended to increase slowly with 
advancing birth weight, but correlation coefficients were low (Walther et al., 1986). 
 
 
 
 
THE IMPORTANCE OF NO RMAL REFERENCE VALUES 
 
 Echocardiography is a leading technology for evaluating cardiovascular structure and function in 
children. As a result life-altering decisions are constantly made on the basis of quantitive 
echocardiographic measurements.  
2.6 THE RELEVANCE OF THE STUDY 
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IT IS A USEFUL AND EFFECTIVE TOOL IN CHILDREN FOR: 
 
 Assessing the effects of medical therapy on the severity of valvular regurgitation and on ventricular 
compensation and function when it might change medical management. 
 Assessing patients with known cardiac defects to determine the timing of medical or surgical 
therapy. 
 Assessing suspected cardiomyopathy, heart failure, and changes in clinical status or to guide medical 
therapy. 
 Screening patients for genetically transmitted cardiovascular disease, such as cardiomyopathy, 
Marfan syndrome, or Ehlers-Danlos syndrome. 
 Conducting baseline evaluation and re-evaluation of patients receiving cardio toxic chemotherapy to 
determine the advisability of additional or increased dosages. 
 Monitoring patients with suspected or documented Kawasaki disease, myopericarditis, human 
immunodeficiency virus (HIV), rheumatic fever, neuromuscular disorder with known myocardial 
involvement, post cardiac or cardiopulmonary transplant, thrombus or cardiac growth, pulmonary 
hypertension, re-evaluation after surgery or initiation of oral or parenteral vasodilator therapy for 
pulmonary hypertension, re-evaluating withdrawal of extracorporeal cardiopulmonary support 
therefore the reliability and validity of these measurements are of great importance(Cheitlin, 
Armstrong, Aurigemma,  Beller,  Bierman, Davis, Douglas, Faxon, Gillam, Kimball, Kussmaul,  
Pearlman, Philbrick, Rakowskie, Thys, Antman, Smith, Alpert, Gregoratus, Anderson, Hiratsuka, Hunt, 
Fuster, Jacobs, Gibbons & Russell 2003; Cheitlin, Alpert, Armstrong, Beller,  Bierman, Davidson, Davis, 
Douglas & Gilliam, 1997). 
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3.1 AIM 
 
To establish reference echocardiographic values for preterm infants of Central South Africa and compare 
them with international standards. 
3.1.1 OBJECTIVES 
 
- to conduct a prospective cross sectional study. 
- with at least 50 children in each weight subgroup (0>0.999g; 1000 g-1499g; 1500 g-2500g). 
- perform size and functional (Doppler Left and Right ventricle) measurements. 
- identify  correlations for gestational age and weight & BSA. 
- compare findings to international standards 
SUB-OBJECTIVES 
 
- effect of Small for Gestational age (SGA) versus Average for Gestational age (AGA) on cardiac 
dimensions. 
- effect of growth on cardiac dimensions. 
3.2 STUDY LOCATION 
 
The study was a multicentre trial involving Universitas Academic, Rosepark and Medi-Clinic Hospitals, 
situated in Bloemfontein, the capital city of the Free State province, South Africa. All infants born in these 
hospitals during the study period were echocardiographically screened to see whether they met the inclusion 
criteria for the study. 
 
 
CHAPTER 3 
METHODOLOGY 
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3.3 STUDY POPULATION 
 
There was endeavored to include a minimum of 50 preterm/low birth weight infants in each weight 
subgroup. The weight subgroups were divided into three groups namely, Group 1 (infants weighing less than 
1000g), Group 2 (infants between 1000-1500g) and Group 3 (infants between 1500-2500g). 
3.3.1    IN- AND EXCLUSION CRITERIA 
INCLUSION CRITERIA 
 Gestational period ≤ 37 weeks.  
 Birth weight less than 2500g. 
 Absence of congenital heart defects excluding:  
Asymptomatic Patent Ductus Arteriosus (PDA) and Patent Foramen Ovale (PFO).  
 Informed consent obtained from parents/guardian. 
 Age 1 – 28 days.  
EXCLUSION CRITERIA 
 Congenital heart defects (excluding hemodynamically insignificant PDA, PFO). 
Definition of hemodynamic significant PDA (exclusion criteria): 
* murmur > gr2/6 on auscultation 
* clinical symptoms and signs of  significant shunt (including cardiac failure) 
* any PDA that requires cardiac medication 
* LA: AO ratio of more than 1,4:1 
 Birth asphyxia. 
 Infants with HIV or suspected HIV or clinical criteria of HIV infection. 
 Clinical heart failure. 
 Cardiac involvement in infectious, neuromuscular or metabolic disorders. 
 Dysrrhythmias. 
 Chronic obstructive airways disease including BPD. 
 Cardio active drugs causing hypertrophy (insulin, inotropes). 
 Clinical, radiological, ECG or echocardiographic evidence of cardiac disease. 
 Babies of mothers with diabetes (gestational and non-gestational). 
 Babies receiving Dexamethazone for chronic lung disease. 
 Major chromosomal abnormalities (e.g. trisomy 21). 
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3.3.2  SUBJECT IDENTIFICATION 
 
Patient confidentiality was maintained throughout the study.  All information (data) was considered 
confidential and no patient names were used to identify the patient but rather the hospital number.  The 
study was conducted according to the rules and regulations from the Ethics Committee of the University of 
the Free State (UFS). 
3.4 STUDY DESIGN 
 
The study design was a prospective, cross sectional study.  
3.5 RESEARCH TEAM 
 
INVESTIGATOR 
Salomi Jacobs- registered degree Master Technologiae Clinical Technology (M.Tech). 
PROJECT LEADER/S 
Prof SC Brown (M. Med. FCPaed DCH ). 
Dr L Botes (D.Tech Molecular Biology). 
COLLABORATORS 
Dr DG Buys (MBChB.M.Med), Miss. R Engelbrecht (B.Tech Clinical Technology). 
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3.6 STUDY LAYOUT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Study Layout 
 
Screened Newborns 
 Gestational age < 37 weeks 
 Birth weight less than 2500 g 
 
Categorized according to birth weight 
 
Group 2 (n = 50) 
 Birth weight 1000 ─ 1499g 
 
Group 3 (n = 50) 
 Birth weight 1500 ─ 2500g 
 
Group 1 (n = 50) 
 Birth weight < 999g 
 
Chamber measurements 
 M-Mode 
 
Functional measurements 
 Doppler MPI: LV & RV 
 
Echocardiographic examination 
 
Functional measurements 
 SF & EF 
 
Longitudinal study: Day1-28 
 Days : 1-28 
Chapter 3 / Methodology   36 
 
The infants born in the mentioned hospitals during the study period were echocardiographically screened. 
Newborns who met the inclusion criteria (<37 weeks gestational age and birth weight less than 2500g) were 
included in the study group. These newborns were divided in 3 weight group categories according to birth 
weight. The research team aimed for each group to consist of at least 50 infants. An echocardiogram was 
performed on each participant and included specific chamber measurements and functional measurements. 
In addition, longitudinal chamber measurements were repeated in a number of infants (n-15) between days’ 
1-28 post birth to gain insight in the  change and growth (refer to Sub-objective). 
3.7 SPECIAL INVESTIGATIO NS  
3.7.1 GESTATIONAL AGE 
 
Gestational age was obtained from the clinical records as recorded by the Neonatologist in charge of each 
patient, using the Ballard score (Ballard et al., 1991; Appendix E). 
3.7.2 DEMOGRAPHIC DATA  
 
The following demographic data was recorded from patient files, by the person performing the 
echocardiogram: 
  
- Date of birth 
- Weight (kg) 
- Length (cm) 
 
Admission diagnosis 
 
- Administered drugs 
- Sex (M/F) 
- Gestational age (days) 
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3.7.3  ECHOCARDIOGRAPHIC EX AMINATION  
 
The echocardiograms were performed in the respective Neonatal Care Units of the three hospitals, where 
they were placed under a warmer or in an Isolette incubator with controlled temperature where careful 
observation and care were given. The participants were not sedated when the echocardiogram was 
performed. Strict measurements to maintain sterility were adhered to. 
 
A Philips Envisor (model: MCMD02AA Type: M2540-66500; Universitas and Rosepark hospitals) and Toshiba 
(serial no: SSA 350A, using 7.5MgHz probe from Toshiba Medical systems, Crawley, UK) (Medi Clinic) 
echocardiography system was used and all images were digitally captured using the Philips Excelera software 
package.  Scanning was done using 5 – 7.5 MHz transducers (S8 or S12). An echocardiogram is non-invasive 
and not harmful or painful to the infants in any way. 
 
Measurements were performed according to the guidelines set by the American Society of Echocardiography 
(ASE)(Sahn et al., 1978). All M-mode values were recorded and an average for 3 sequential beats was 
calculated. In order to control inter-observer variability, a Pediatric Cardiologist randomly selected patients 
and re-measured them to confirm accuracy and repeatability. 
 
All M-mode and 2D measurements were repeated 3 times and the MPI index, 5 times, during the same 
echocardiographic examination and the results averaged. 
 
Factors related to the clinical interpretation of the echocardiogram, i.e. the selection of the structure 
interfaces, and the specific criteria for echocardiography measurements, were addressed by standardized 
criteria and examination practices beforehand. This assured consistency and quality as far as possible. 
REPRODUCIBILITY 
 
Intra-observer variability of the M-mode and MPI-index measurements were addressed by randomly 
selecting 15 cases that were analyzed by observers as well as by one independent observer. The 
measurements were performed on digital recordings; each was blinded to the results obtained by the others. 
Variability was calculated as the mean percentage error, derived as the difference between the four sets of 
measurements, divided by the mean of the observations. 
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RECORDED ECHOCARDIOGRAPHIC MEASUREMENTS  
 SHORTENING FRACTION (SF %) 
 EJECTION FRACTION (EF %) 
 LEFT VENTRICLE END DIASTOLIC MEASUREMENT (LVEDD) IN MM 
 LEFT VENTRICLE END SYSTOLIC MEASUREMENT (LVESD) IN MM 
 POSTERIOR WALL THICKNESS IN DIASTOLE (PW) IN MM 
 INTERVENTRICULAR SEPTUM THICKNESS IN DIASTOLE (IVS) IN MM 
 LEFT ATRIAL MEASUREMENT 2D AND 4 CHAMBER (LA2D & LA) IN MM 
 AORTIC ROOT MEASUREMENT (AOR) IN MM 
 AORTIC CUSP SEPARATION (ACS) IN MM 
 MUSCLE PERFORMANCE INDEX (MPI)-INDEX (LEFT AND RIGHT VENTRICLE) 
 MITRAL AND TRICUSPID VALVE ORIFICES IN MM. 
 
3.7.3.1   CARDIAC M-MODE AND 2D MEASUREMENTS 
 
A diagram indicating the methods for measuring M-Mode are displayed in Appendix D. M-mode 
measurements were done on the parasternal long-axis view. The left ventricle internal dimension in systole 
and diastole (LVESD & LVEDD) was measured from the trailing edge of the left side of the septum to the 
leading edge of the posterior endocardium. Posterior left ventricular wall thickness (PW) represents the 
distance between the leading edge of the posterior left ventricular endocardium and the leading edge of the 
epicardium. Interventricular septal wall thickness (IVS) was the distance between the leading edge of the left 
septal echo and the trailing edge of the right septal echo. PW and IVS measurements are recorded in diastole, 
(IVSd and PWd). Left atrial (LA) dimension represented the distance between the trailing edge of the 
posterior aortic wall echo and the leading edge of the posterior left atrial wall echo at the level of the aortic 
valve at end-systole. Left atrial 2–dimensional (LA 2D) dimension represented the area from inner edge to 
inner edge on a diagonal and on a longitudinal view . 
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Aortic root (AoR) dimension is the distance between the leading edge of the anterior aortic wall and the 
leading edge of the posterior aortic wall immediately pre-systolic. 
 
Tricuspid valve orifice and mitral valve orifice was measured from hingepoints to hingepoints, at the point 
where valves were most opened during diastole. 
 
Aortic cusp separation (ACS) represents the distance between the trailing edge of the anterior aortic valve 
leaflet and the leading edge of the posterior aortic valve leaflet in early systole. 
 
According to the recommendations of the American Society of Echocardiography (ASE) end-diastole should 
be measured at the beginning of the QRS-complex.  However, in children this may lead to errors and 
measuring at the largest and smallest ventricular dimension may be more appropriate than measuring at 
specific times on the electrocardiogram. Measuring from leading edge to leading edge of the M-mode trace 
was the preferred technique.  Measurements for premature infants was done as recommended by Silverman 
and co-workers (1993) and accepted by ASE (Sahn et al., 1978; Appendix D). 
3.7.3.2   CALCULATING MUSCLE PERFORMANCE INDEX (MPI)  
 
The MPI was calculated by measurements done in the supine position in the apical 4 chambers and apical 
long axis views. An average of 5 consecutive cycles was used. A pulsed-wave Doppler sample volume (set at 
2mm width) was taken at certain specific points on a four-chamber view.  The first sample was taken at the 
left ventricle outflow tract right below the aortic valve cusps. Another sample volume was taken at the tips of 
the mitral valve leaflets in diastole.   The size of the Doppler sample volume was set between 2-4mm with a 
400Hz wall-filter setting. Care was taken to align the transducer beam as close as possible to the Doppler 
beam at  20 degrees in the selected planes. No angle correction of the Doppler beam was allowed. The 
sample volumes represented isovolumetric contraction time (ICT), isovolumetric relaxation time (IRT) and 
ejection time (ET). 
LEFT HEART MPI 
 
 The MPI formula is (a-b)/b; a being ICT + IRT + ET and b equaling ET (Tei et al., 1995). 
 a was measured from the end of one mitral valve inflow profile to the beginning of the following mitral 
valve inflow pattern.  
 b was the measured length of the aortic valve outflow profile.  
 Mitral valve (MiV) flow: trailing edge – leading edge for measurement.  
 Aortic valve (AoV) flow: outer – inner edge (Tei et al., 1995). 
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RIGHT HEART MPI 
 
 The MPI formula is (a-b)/b; a being ICT + IRT + ET and b equaling ET (Tei et al., 1995).  
 a was measured from the end of one tricuspid valve inflow profile to the beginning of the following 
tricuspid valve inflow pattern. 
 b was the measured length of the pulmonary valve outflow profile. 
 Tricuspid Valve (TV) flow: trailing edge – leading edge for measurement. 
 Pulmonary Valve (PuV) flow: outer – inner edge (Tei et al.,  1995). 
3.8 STATISTICAL ANALYSIS  
 
All the statistical analyses were performed by the department of biostatistics, University of the Free State. 
The values for all measured dimensions were expressed as a function of body surface area (BSA) and weight. 
Raw data was captured on Excell spreadsheets. Normal ranges were calculated using means plus/minus 2 
standard deviations or 2.5 and 97.5 percentiles depending on the distribution of the data, for different 
categories of underweight babies. Comparisons with the literature were carried out using 95% confidence 
intervals or P-values depending on the data available. Analysis was done using Statistical Analysis Software 
(SAS). 
3.9 ETHICAL ASPECTS AND GOOD CLINICAL PRACTICE 
3.9.1   ETHICAL CLEARANCE  
 
Permission was obtained from the Ethical Committee of the Free State (ETOVS 166/05; Appendix C) and 
permission to use clinical records from the Chief Executive Officer of the respective hospitals (Appendix B).  
Fully informed, written consent were obtained from the parent/ legal guardian of each participating infant 
(Appendix A). Each parent or legal guardian received an information leaflet to explain the study in lay terms 
(Appendix A). 
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3.9.2   SAFETY VARIABLES  
3.9.2.1   PROJECT SAFETY 
 
The investigations were painless, non-invasive and completely safe.  Any abnormality detected was reported 
to the treating physician with recommendation for referral to a Cardiologist. 
 
3.9.2.2    PREMATURE DISCONTINUATION OF THE STUDY 
 
The study would have been discontinued prematurely if the researcher or any of the study leaders felt that a 
patient’s confidentiality might have been breached or if any unethical procedures may have occurred. 
 
3.9.2.3    GOOD CLINICAL PRACTICE (GCP) / QUALITY ASSURANCE 
 
All clinical work conducted under this dissertation was subjected to the South African Good Clinical Practice 
guidelines (The Principles of ICH GCP, 2004). 
 
3.9.2.4    FINANCIAL IMPLICATIONS TO THE PATIENT 
 
There were no financial implications to the families of any of the participants in the study. 
 
3.9.2.5    WITHDRAWAL CRITERIA 
 
Participation was completely voluntarily.  Patients had the right to withdraw from the study at any time, 
irrespective the reason(s), without detriment to their medical care then or in the future.  The elimination of a 
patient from this study did not involve any penalty. 
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4.1 BACKGROUND 
 
All data were captured electronically on a Microsoft Excel spreadsheet.  Statistical analysis was carried out by 
a bio-statistician using Statistical Analysis Software (SAS) Version 9.1.3. Descriptive statistics including 
frequencies and percentages were calculated for categorical data. Means and standard deviations or medians 
and percentiles were calculated for numerical data. Analytical statistics was used to compare intra- and inter-
observer variation. Original data is presented in tabular format followed by modified tables for clinical use.  
All p-values <0.05 were classified as being statistically significant. All data will be presented in the order of 
raw data, then data for clinical use followed by regression analysis figures. 
4.2 STUDY POPULATION  
4.2.1 DEMOGRAPHIC DATA  
 
During a 12 month (1st May 2009 - 30 May 2010) study period two hundred and ninety (n = 290) infants met 
the inclusion criteria and participated in the research study for low birth weight infants. The study was 
conducted in 3 hospitals in Central South Africa namely Universitas Academic hospital, Life- Healthcare Rose 
Park hospital and Medi- clinic hospital in Bloemfontein. The racial distribution consisted of the following: 
15/290 (5.1%) Caucasian and the rest, non-Caucasian (94.8%). 
 
The gender distribution was almost equal for male and female with a slight female preponderance. There 
were 135 (46%) male and 155 (53%) female infants that participated in the study (Figure 4.1). The 
gestational age ranged between 26-38 weeks, with a median of 31 weeks.  
 
Eleven infants (3.8%) who were exposed to HIV during pregnancy were included in the study because they 
did not meet any of the clinical exclusion criteria. The age at which the infants received the echocardiogram 
ranged between one and 24 days, with a median of 4 days-excluding the longitudinal study where infants 
received an echocardiogram on day 1-7 after birth, at day 14 and at 28 days after birth. 
 CHAPTER 4 
 RESULTS 
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Figure 4.1 Gender Distribution 
4.2.2 ANTHROPOMETRIC MEASUREMENTS 
 
Body surface area (BSA) ranged between a minimum of 0.076 m² and a maximum of 0.184 m², with a median 
of 0.121 m². The body weight (BW) ranged between a minimum of 0.69 kg and a maximum of 2.5 kg, with a 
median of 1.36 kg for the entire study population (n=290)(Table 4.1). 
 
TABLE 4.1 ANTHROPOMETRIC DATA (n=290) 
Variable Minimum Maximum Median 
Weight 0.69 kg 2.5 kg 1.36 kg 
Length 28 cm 51 cm 38 cm 
BSA 0.076 m² 0.184 m² 0.121 m² 
Age at time of 
investigation 
1 day  24 days 4 days 
[kg = kilogram; cm = centimetre; m² = meters squared; BSA = Body Surface Area; Age = days after birth) 
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4.3 DATA PER WEIGHT CATEGORY 
 
Infants were classified into 3 groups according to their weight (Figure 4.2); Group 1 (<0.999g), Group 2 
(1000-1499g), and Group 3 (1500- 2500g). The majority of the infants fell in Group 2 (n=135; 45%) and the 
minority in Group 1(n=44; 15%).  
 
 
 
Figure 4.2 Weight Categorization  
(Group 1 = <0.999g; Group 2 = 1000-1499g; Group 3 = 1500-2500g) 
4.3.1 DEMOGRAPHIC DATA 
 
For the entire study population and for all the weight categories the gender was almost equal with a very 
slight female preponderance. The gender distribution percentages were as follow: Group 1 (43% male & 56% 
female) Group 2 (46% male & 54% female) Group 3 (48% male & 52% female). 
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Figure 4.3 Gender distributions per Category 
(Group 1 = <0.999g; Group 2 = 1000-1499g; Group 3 = 1500- 2500g) 
 
4.3.2 ANTHROPOMETRIC MEASUREMENTS PER WEIGHT CATEGORY  
 
The BSA increased with an increase in weight for all three the groups. The median BSA for the 3 groups was; 
Group 1 (0.09 m2), Group 2 (0.11 m²) and Group 3 (0.14 m²) respectively (Table 4.2).  
TABLE 4.2 ANTHROPOMETRIC DATA PER WEIGHT CATEGORY  
VARIABLE GROUP 1 GROUP 2 GROUP 3 
Weight 
minimum 
maximum 
median 
0.69 kg 
1.00 kg 
0.91 kg 
1.01 kg 
1.50 kg 
1.25 kg 
1.54 kg 
2.50 kg 
1.93 kg 
Length 
minimum 
maximum 
median 
29 cm 
39 cm 
34 cm 
28 cm 
45 cm 
37 cm 
30 cm 
51 cm 
42 cm 
BSA 
minimum 
maximum 
median 
0.076 m² 
0.103 m² 
0.094 m² 
0.096 m² 
0.129 m² 
0.113 m² 
0.123 m² 
0.184 m² 
0.149 m² 
(Group 1 = <0.999g; Group 2 = 1000-1499g; Group 3 = 1500- 2500g; kg = kilogram; cm = centimetre; m² = meters 
squared; BSA = Body Surface Area) 
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4.3.3 WEIGHT VS. BODY SURFACE AREA (BSA)  
 
The weight correlated well with BSA and a strong correlation was observed between the BSA and weight in 
these infants (r= 0.98; Figure 4.4).  
 
Fig. 4.4 Weight vs. Body Surface Area (BSA) 
(BSA = Body Surface Area; Weight = weight in grams) 
4.3.4 SMALL FOR GESTATIONAL AGE (SGA) VERSUS AVERAGE FOR 
GESTATIONAL AGE (AGA) FOR GROUPS 1-3 
 
 Small for gestational age (SGA): “defined as babies whose birth weight lies below the 10th percentile for a 
specific gestational age, they may be full term or preterm infants” 
 Average for gestational age (AGA): “defined as babies whose birth weight is within the normal percentiles for  a 
specific gestational  age,  they may be full term or preterm infants” 
 
SGA infants made up 29.7% (n= 87) of the entire study population. The number of SGA versus AGA infants for 
each group: 
 
 Group 1: SGA (n = 18);  AGA infants (n = 26) 
 Group 2: SGA (n = 36);  AGA infants (n = 96) 
 Group 3: SGA (n = 33);  AGA infants (n = 81) 
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The majority of SGA’s were in Group 1 (41%) and the majority of AGA infants (73%) were in Group 2 (Figure 
5.5). 
 
 
 
Figure 4.5 SGA versus AGA infants per Group 1-3  
(Group 1 = <0.999g; Group 2 = 1000-1499g; Group 3 = 1500-2500g) 
4.4. ECHOCARDIOGRAPHIC MEASUREMENTS 
 
M-mode, 2D and functional measurements were analyzed for differences in appropriate for gestational age 
versus small for gestational age. There were no statistical differences between the two groups for any of the 
cardiac dimensions (p<0.05).  
 
Comparisons between male and female for all weight groups were performed and no statistical differences 
were observed when the two gender groups were compared (p<0.05) for M-mode, 2D and functional 
measurements. 
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4.4.1.  M-MODE MEASUREMENTS (G ROUP 1-3)  
 
Most cardiac dimensions measured larger on average in the heavier weight categories than in the smaller 
weight categories (Figure 4.3-4.5). The left ventricular diastolic and systolic, interventricular septum, 
posterior wall, aortic and left atrium dimensions showed a proportionate increase in diameter with an 
increase in body weight (Figure 4.6). 
 
The M-mode examination consisted of left ventricle, left atrium and aortic root and cusp measurements. The 
M-mode left ventricle values per group are given in mm, with upper limits (z+2) and lower limits (z-2; Table 
4.3-4.5).  This is followed by the M-mode left ventricle values for SGA infants versus AGA infants (Table 4.6-
4.8).  
TABLE 4.3 M-MODE GROUP 1 (WEIGHT CATEGORY <0.999g) 
Variable 
Mean 
(n=44) 
Std dev 
(n=44) 
z-2 z+2 
LVEDD 12.03 2.38 7.36 16.71 
LVESD 7.86 1.51 4.39 10.84 
PWd 3.18 0.60 2.00 4.36 
IVSd 3.34 6.17 2.13 4.55 
LA 8.76 2.00 4.88 12.68 
AoR 6.85 1.20 4.49 9.21 
ACS 4.05 0.78 2.50 5.50 
(LVEDD = left ventricle end-diastolic diameter; LVESD = left ventricle end-systolic diameter; PW = posterior wall; IVS = 
interventricular septum; LA = left atrium; AoR = aortic root; ACS = aortic cusps separation; STD dev = standard deviation) 
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TABLE 4.4 M-MODE GROUP 2 (WEIGHT CATEGORY 1000-1499g) 
Variable 
Mean 
(n = 132) 
Std dev 
(n = 132) 
z-2 Z+2 
LVEDD 12.45 1.87 8.77 16.13 
LVESD 8.13 1.50 5.19 11.07 
PWd 3.26 0.59 2.10 4.42 
IVSd 3.33 0.61 2.05 4.61 
LA 8.95 1.45 6.09 11.81 
AoR 7.22 1.31 4.6 9.79 
ACS 4.70 0.95 2.83 6.57 
(LVEDD = left ventricle end-diastolic diameter; LVESD = left ventricle end-systolic diameter; PW = posterior wall; IVS = 
interventricular septum; LA = left atrium; AoR = aortic root; ACS = aortic cusps separation; STD dev = standard deviation) 
 
TABLE 4.5 M-MODE GROUP 3 (WEIGHT CATEGORY 1500-2500g) 
Variable 
Mean 
(n = 114) 
Std dev 
(n = 114) 
z-2 z+2 
LVEDD 14.24 2.13 10.06 18.43 
LVESD 9.30 1.65 6.05 12.56 
PWd 3.58 0.72 2.15 5.00 
IVSd 3.77 0.69 2.42 5.13 
LA 10.85 2.10 6.72 14.99 
AoR 8.26 1.40 5.51 11.02 
ACS 5.43 1.33 2.81 8.04 
(LVEDD = left ventricle end-diastolic diameter; LVESD = left ventricle end-systolic diameter; PW = posterior wall; IVS = 
interventricular septum; LA = left atrium; AoR = aortic root; ACS = aortic cusps separation; STD dev = standard deviation) 
 
 
Chapter 4 / Results   50 
 
TABLE 4.6 M-MODE AGA VS SGA GROUP 1 (WEIGHT CATEGORY <0.999g) 
Variable 
Mean(AGA) 
(n=26) 
Std dev(AGA) 
Mean(SGA) 
(n=18) 
Std dev(SGA) 
LVEDD 11.98 0.24 12.01 0.24 
LVESD 8.01 0.17 7.66 0.13 
PWd 3.26 0.07 3.07 0.03 
IVSd 3.28 0.06 3.42 0.06 
LA 8.84 0.21 8.64 0.19 
AoR 6.83 0.13 6.89 0.11 
ACS 4.16 0.09 3.88 0.05 
(LVEDD = left ventricle end-diastolic diameter; LVESD = left ventricle end-systolic diameter; PW = posterior wall; IVS = 
interventricular septum; LA = left atrium; AoR = aortic root; ACS = aortic cusps separation; STD dev = standard deviation;  
AGA= Average for Gestational Age; SGA= Small for Gestational Age) 
TABLE 4.7 M-MODE AGA VS SGA GROUP 2 (WEIGHT CATEGORY 1000-1499g) 
Variable 
Mean(AGA) 
(n=96) 
Std dev(AGA) 
Mean(SGA) 
(n=36) 
Std dev(SGA) 
LVEDD 12.61 0.19 12.03 0.19 
LVESD 8.22 0.14 7.89 0.17 
PWd 3.29 0.06 3.15 0.06 
IVSd 3.39 0.07 3.17 0.05 
LA 9.02 0.15 8.75 0.15 
AoR 7.18 0.14 7.30 0.01 
ACS 4.75 0.10 4.57 0.08 
(LVEDD = left ventricle end-diastolic diameter; LVESD = left ventricle end-systolic diameter; PW = posterior wall; IVS = 
interventricular septum; LA = left atrium; AoR = aortic root; ACS = aortic cusps separation; STD dev = standard deviation; 
AGA= Average for Gestational Age; SGA= Small for Gestational Age) 
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TABLE 4.8 M-MODE AGA VS SGA GROUP 3 (WEIGHT CATEGORY 1500-2500g) 
Variable 
Mean(AGA) 
(n=81) 
Std dev(AGA) 
Mean(SGA) 
(n=33) 
Std dev (SGA) 
LVEDD 14.38 0.22 13.92 0.19 
LVESD 9.37 0.18 9.13 0.13 
PWd 3.58 0.08 3.55 0.06 
IVSd 3.75 0.07 3.82 0.06 
LA 10.85 0.20 10.86 0.24 
AoR 8.23 0.13 8.35 0.16 
ACS 5.42 0.13 5.43 0.15 
(LVEDD = left ventricle end-diastolic diameter; LVESD = left ventricle end-systolic diameter; PW = posterior wall; IVS = 
interventricular septum; LA = left atrium; AoR = aortic root; ACS = aortic cusps separation; STD dev = standard deviation; 
AGA= Average for Gestational Age; SGA= Small for Gestational Age) 
The measurements for clinical use are displayed in Table 4.9 and all the measurements are in mm.  A z score 
of -3 is included in frequently used measurements as a quick reference to determine hypoplasia (Table 4.9). 
TABLE 4.9 M-MODE LEFT VENTRICLE INTERNAL DIMENSIONS FOR CLINICAL USE 
Variable Mean & Z Score 
 
GROUP 1 
 
Weight Category 
<0.999g 
 
GROUP 2 
 
Weight Category 
1000-1499g 
 
GROUP 3 
 
Weight Category 
1500-2500g 
LVEDD Mean 12 12.5 14.2 
(mm) z+2 16.7 16.1 18.4 
 z-2 7.4 8.8 10.1 
 z-3 4.9 6.8 7.9 
LVESD Mean 7.9 8.1 9.3 
(mm) z+2 10.8 11.1 12.6 
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 z-2 4.4 5.2 6.l 
 z-3 3.3 3.6 4.3 
PWd Mean 3.2 3.3 3.6 
mm z+2 4.4 4.4 5 
 z-2 2 2.1 2.2 
 z-3 1.4 1.5 1.40 
IVSd Mean 3.3 3.3 3.8 
mm z+2 4.6 4.6 5.1 
 z-2 2.1 2 2.4 
 z-3 1.5 1.4 1.7 
LA Mean 8.8 8.9 10.9 
Mm z+2 12.7 11.8 15 
 z-2 4.9 6.1 6.7 
 z-3 2.8 4.6 4.5 
AoR Mean 6.9 7.2 8.3 
Mm z+2 9.2 9.8 11 
 z-2 4.5 4.6 5.5 
 z-3 3.2 3.3 4.0 
ACS Mean 4 4.7 5.4 
Mm z+2 5.5 6.6 8 
 z-2 2.5 2.8 2.8 
 z-3 1.7 1.8 1.4 
(LVEDD = left ventricle end-diastolic diameter; LVESD = left ventricle end-systolic diameter; PW = posterior wall; IVS = 
interventricular septum; LA = left atrium; AoR = aortic root; ACS = aortic cusps separation) 
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Regression analysis showed a positive correlation between LVEDD and body weight for the group as a whole 
(r= 0.49, p <0. 05). 
 
 
Figure 4.6 Linear regression analyses for LVEDD measurements. 
(LVEDD = left ventricle end-diastolic diameter (mm) and weight (grams) 
 
4.4.2 TWO DIMENSIONAL ECHO CARDIOGRAPHIC MEASUREMENTS: MITRAL 
AND TRICUSPID VALVE  
 
The mitral and tricuspid annular diameter increased as weight increased in the three groups (Table 4.10-4.12 
& Figure 4.7). Interestingly, tricuspid valve dimensions mirrored mitral valve diameters. There was a 
correlation between these two dimensions (r = 0.69 and p<0.05; Figure 4.8). the LA 2d measurements was 
not reported, we excluded these measuements due to the high variance and subjectivity of the 
measurements.  
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TABLE 4.10 MITRAL & TRICUSPID ANNULUS GROUP 1 (WEIGHT CATEGORY<0.999g) 
Variable 
Mean 
(n=44) 
Std dev 
(n=44) 
z-2 z+2 
MV annulus 5.92 0.86 4.24 7.60 
TV annulus 6.06 0.89 4.31 7.81 
(MV = mitral valve; TV = tricuspid valve; STD dev = standard deviation) 
 
 
TABLE 4.11 MITRAL & TRICUSPID ANNULUS GROUP 2 (WEIGHT CATEGORY 1000-
1499g) 
Variable 
Mean 
(n=132) 
Std dev 
(n=132) 
z-2 z+2 
MV annulus 6.40 0.96 4.53 8.28 
TV annulus 6.50 1.00 4.54 8.47 
(MV = mitral valve; TV = tricuspid valve; STD dev = standard deviation) 
 
 
TABLE 4.12 MITRAL & TRICUSPID ANNULUS GROUP 3 (WEIGHT CATEGORY 1500-
2500g) 
Variable 
Mean 
(n=144) 
Std dev 
(n=144) 
z-2 z+2 
MV annulus 7.26 1.21 4.89 9.63 
TV annulus 7.50 1.31 4.93 10.08 
(MV = mitral valve; TV = tricuspid valve; STD dev = standard deviation) 
 
The differences between the SGA and AGA infants for all weight categories are displayed in Table 4.13-4.15.  
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TABLE 4.13 MITRAL & TRICUSPID ANNULUS AGA VS SGA GROUP 1 (WEIGHT 
CATEGORY<0.999g) 
Variable 
Mean(AGA) 
(n=26) 
Std dev(AGA) 
Mean(SGA) 
(n=18) 
Std dev(SGA) 
MV annulus 5.84 0.98 6.04 0.65 
TV annulus 6.05 0.99 6.08 0.76 
(MV = mitral valve; TV = tricuspid valve; STD dev = standard deviation: AGA= Average for Gestational Age; SGA= Small for 
Gestational Age) 
 
TABLE 4.14 MITRAL & TRICUSPID AGA VS SGA ANNULUS GROUP 2 (WEIGHT 
CATEGORY 1000-1499g) 
Variable 
Mean(AGA) 
(n=96) 
Std dev(AGA) 
Mean(SGA) 
(n=36) 
Std dev(SGA) 
MV annulus 6.48 0.95 6.20 0.96 
TV annulus 6.63 1.02 6.16 0.87 
(MV = mitral valve; TV = tricuspid valve; STD dev = standard deviation: AGA= Average for Gestational Age; SGA= Small for 
Gestational Age) 
 
TABLE 4.15 MITRAL & TRICUSPID ANNULUS AGA VS SGA GROUP 3 (WEIGHT 
CATEGORY 1500-2500g) 
Variable 
Mean(AGA) 
(n=81) 
Std dev(AGA) 
Mean(SGA) 
(n=33) 
Std dev(SGA) 
MV annulus 7.26 1.30 7.25 0.96 
TV annulus 7.51 1.37 7.47 1.18 
(MV = mitral valve; TV = tricuspid valve; STD dev = standard deviation: AGA= Average for Gestational Age; SGA= Small for 
Gestational Age) 
 
The measurements for clinical use for group 1-3 are measured in mm (Table 4.16). 
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TABLE 4.16 MITRAL AND TRICUSPID VALVE ANNULAR DIAMETERS FOR CLINICAL 
USE 
Variable Mean & Z score 
 
GROUP 1 
 
Weight Category 
<0.999g 
 
GROUP 2 
 
Weight Category 
1000-1499g 
 
GROUP 3 
 
Weight Category 
1500-2500g 
MV annulus Mean 5.9 6.4 7.3 
 z+2 7.6 8.3 9.7 
 z-2 4.2 4.5 4.9 
 z-3 3.3 3.5 3.6 
TV annulus Mean 6.1 6.5 7.5 
 z+2 7.8 8.5 10.1 
 z-2 4.3 4.5 4.9 
 z-3 3.4 3.5 3.5 
(MV = mitral valve; TV = tricuspid valve; STD dev = standard deviation) 
 
 
Figure 4.7 Linear regression analysis for all mitral valve annulus measurements (n=290) 
(MiV = Mitral valve orifice in (mm) and weight (grams) 
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Figure 4.8 Linear regression analysis for all tricuspid valve annulus measurements (n=290) 
(TiV = Tricuspid valve orifice in (mm) and weight (grams) 
MiV
T
iV
5 10 15
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Figure 4.9 Linear regression analysis between the Mitral valve annulus and Tricuspid valve 
annulus (n=290). 
(TiV = Tricuspid valve orifice in (mm); MiV = Mitral valve orifice in (mm)) 
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4.4.3   FUNCTIONAL ASSESSMENT 
 
Functional measurements included systolic assessment via the shortening and ejection fraction derived from 
M-mode measurements as well as global systolic and diastolic derived functional assessments using Doppler 
for the calculation of the myocardial performance index (MPI) for the RV and LV.  
 
4.4.3.1  M-MODE FUNCTIONAL ANALYSIS  
 
The ejection fraction and shortening fraction remained constant over all the weight categories with a mean 
shortening fraction of 34% and mean ejection fraction of 67%. There was no correlation between SF and 
weight (Figure 4.10). The SF remained constant although there was an increase in the weight of the infants (r 
= 0.02). 
 
The Doppler MPI for the left ventricle was 0.22 and for the right 0.29 (Table 4.30) and also remained more or 
less unchanged for all weight categories. There was a positive correlation between the left ventricular 
Doppler MPI and the SF (Fig.4.14) and EF (r = 0.68).  
 
The data for the shortening fraction and ejection fraction per weight category are displayed in Table 4.17-
4.19. 
TABLE 4.17 SHORTENING & EJECTION FRACTION GROUP 1 (WEIGHT 
CATEGORY<0.999g) 
Variable 
Mean 
(n = 44) 
Std dev 
(n = 44) 
z-2 z+2 
SF% 34.8 5.8 23.4 46.3 
EF% 68.4 7.7 53.3 83.5 
(SF = shortening fraction; EF = ejection fraction; STD dev = standard deviation) 
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TABLE 4.18 SHORTENING & EJECTION FRACTION GROUP 2 (WEIGHT CATEGORY 
1000-1499g) 
Variable 
Mean 
(n = 132) 
Std dev 
(n = 132) 
z-2 z+2 
SF% 34.5 6.3 22.1 46.9 
EF% 67.6 8.5 50.9 84.3 
(SF = shortening fraction; EF = ejection fraction; STD dev = standard deviation) 
 
TABLE 4.19 SHORTENING & EJECTION FRACTION GROUP 3 (WEIGHT CATEGORY 
1500-2500g) 
Variable 
Mean 
(n = 114) 
Std dev 
(n = 114) 
z-2 z+2 
SF% 34.5 6.0 22.8 46.3 
EF% 66.8 8.1 51.1 83.0 
(SF = shortening fraction; EF = ejection fraction; STD dev = standard deviation) 
 
 
The differences for shortening fraction and ejection fraction between SGA and AGA infants for all weight 
categories are displayed in Table 4.20-4.22.  
TABLE 4.20 SHORTENING & EJECTION FRACTION AGA VS SGA GROUP 1 (WEIGHT 
CATEGORY<0.999g)  
Variable 
Mean(AGA) 
(n=26) 
Std dev(AGA) 
Mean(SGA) 
(n=18) 
Std dev(SGA) 
SF % 34.5 5.3 35.3 6.7 
EF % 68.0 7.2 69.0 8.6 
(SF = shortening fraction; EF = ejection fraction; STD dev = standard deviation: AGA= Average for Gestational Age; SGA= 
Small for Gestational Age) 
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TABLE 4.21 SHORTENING & EJECTION FRACTION AGA VS SGA GROUP 2 (WEIGHT 
CATEGORY 1000-1499g)  
Variable 
Mean(AGA) 
(n=96) 
Std dev(AGA) 
Mean(SGA) 
(n=36) 
Std dev(SGA) 
SF % 34.7 6.3 34.1 6.6 
EF % 67.7 8.4 67.4 9.0 
(SF = shortening fraction; EF = ejection fraction; STD dev = standard deviation: AGA= Average for Gestational Age; SGA= 
Small for Gestational Age) 
TABLE 4.22 SHORTENING & EJECTION FRACTION AGA VS SGA GROUP 3 (WEIGHT 
CATEGORY 1500-2500g) 
Variable 
Mean(AGA) 
(n=81) 
Std dev(AGA) 
Mean(SGA) 
(n=330 
Std dev(SGA) 
SF % 34.7 6.2 34.2 5.5 
EF % 67.1 8.4 66.7 7.5 
 (SF = shortening fraction; EF = ejection fraction; STD dev = standard deviation: AGA= Average for Gestational Age; SGA= 
Small for Gestational Age) 
TABLE 4.23 SHORTENING & EJECTION FRACTION FOR CLINICAL USE 
Variable Mean & Z score 
 
GROUP 1 
 
Weight Category 
<0.999g 
 
GROUP 2 
 
Weight Category 
1000-1499g 
 
GROUP 3 
 
Weight Category 
1500-2500g 
SF % Mean 35 35 35 
 z+2 46 47 46 
 z-2 23 22 23 
EF % Mean 68 68 67 
 z+2 84 84 83 
 z-2 53 50 51 
(SF = shortening fraction; EF = ejection fraction) 
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(g) 
Shortening fractions for the group (n=290) remained constant (Figure 4.10) including for the SGA and AGA 
infants. Due to the fact that ejection fraction is not commonly applied in children; a regression analysis was 
not done for EF. 
 
 
Figure 4.10 Linear regression analysis for all SF % measurements (n=290; weight (g)) 
 
4.4.3.2 DOPPLER MPI 
 
Doppler echocardiography was used to determine left and right ventricle MPI (Table 4.24-4.26).  Overall, MPI 
remained similar for the whole study population (n=290). The left and right ventricle MPI was calculated for 
the SGA versus the AGA infants (Table 4.24-4.26) followed by a table for clinical use per weight category 
(Table 4.30). No correlation was observed between weight and LV MPI values for preterm/low birth weight 
infants (r = 0.02, p = 0.69; Figure 4.10).  A similar finding was demonstrated for RV MPI values (Figure 4.11). 
Although there was a tendency for the RV MPI to be lower as weight increased, no correlation was present (r 
= 0.02, p = 0.68).   
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TABLE 4.24 MPI LEFT AND RIGHT VENTRICLE GROUP 1 (WEIGHT 
CATEGORY<0.999g) 
Variable 
Mean 
(n=44) 
Std dev 
(n=44) 
z-2 z+2 
MPI LV 0.31 0.12 0.07 0.55 
MPI RV 0.23 0.18 0.13 0.59 
(MPI= Myocardial performance index; RV = right ventricle, LV = left ventricle; STD dev = standard deviation) 
 
TABLE 4.25 MPI LEFT AND RIGHT VENTRICLE GROUP 2 (WEIGHT CATEGORY 1000-
1499g)  
Variable 
Mean  
(n=132) 
Std dev 
(n=132) 
z-2 z+2 
MPI LV 0.29 0.15 0.00 0.59 
MPI RV 0.22 0.15 0.08 0.52 
(MPI= Myocardial performance index; RV = right ventricle, LV = left ventricle: STD dev = standard deviation) 
 
TABLE 4.26 MPI LEFT AND RIGHT VENTRICLE GROUP 3 (WEIGHT CATEGORY 1500-
2500g) 
Variable 
Mean 
(n=114) 
Std dev 
(n=114) 
z-2 z+2 
MPI LV 0.29 0.15 0.00 0.59 
MPI RV 0.23 0.13 0.03 0.48 
(MPI= Myocardial performance index; RV = right ventricle, LV = left ventricle: STD dev = standard deviation) 
TABLE 4.27 MPI LEFT AND RIGHT VENTRICLE AGA VS SGA GROUP 1 (WEIGHT 
CATEGORY<0.999g) 
Variable 
Mean(AGA) 
(n=26) 
Std dev(AGA) 
Mean(SGA) 
(n=18) 
Std dev(SGA) 
MPI LV 0.32 0.10 0.29 0.15 
MPI RV 0.23 0.17 0.23 0.20 
(MPI= Myocardial performance index; RV = right ventricle, LV = left ventricle: STD dev = standard deviation: AGA= 
Average for Gestational Age; SGA= Small for Gestational Age) 
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TABLE 4.28 MPI LEFT AND RIGHT VENTRICLE AGA VS SGA GROUP 2 (WEIGHT 
CATEGORY 1000-1499g)   
Variable 
Mean(AGA) 
(n=96) 
Std dev(AGA) 
Mean(SGA) 
(n=36) 
Std dev(SGA) 
MPI LV 0.27 0.13 0.26 0.17 
MPI RV 0.22 0.16 0.22 0.12 
(MPI= Myocardial performance index; RV = right ventricle, LV = left ventricle; STD dev = standard deviation: AGA= 
Average for Gestational Age; SGA= Small for Gestational Age) 
 
TABLE 4.29 MPI LEFT AND RIGHT VENTRICLE AGA VS SGA GROUP 3(WEIGHT 
CATEGORY 1500-2500g)  
Variable 
Mean(AGA) 
(n=81) 
Std dev(AGA) 
Mean(SGA) 
(n=33) 
Std dev(SGA) 
MPI LV 0.32 0.16 0.24 0.12 
MPI RV 0.24 0.12 0.20 0.16 
(MPI= Myocardial performance index; RV = right ventricle, LV = left ventricle: STD dev = standard deviation: AGA= 
Average for Gestational Age; SGA= Small for Gestational Age) 
 
TABLE 4.30 MPI LEFT AND RIGHT VENTRICLE FOR CLINICAL USE   
Variable Mean & Z score 
 
GROUP 1 
 
Weight Category 
<0.999g 
 
GROUP 2 
 
Weight Category 
1000-1499g 
 
GROUP 3 
 
Weight Category 
1500-2500g 
MPI LV Mean 0.31 0.29 0.29 
 
Z+2 0.60 0.60 0.60 
  
Z-2 0.06 0.001 0.001 
MPI RV Mean 0.23 0.22 0.23 
 
Z+2 0.60 0.50 0.50 
  
Z-2 0.10 0.08 0.03 
(MPI= Myocardial performance index; RV = right ventricle, LV= left ventricle) 
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Figure 4.11 Linear regression analysis for Left ventricle MPI index values versus weight 
(n=290). 
(MPI= Myocardial performance index, LV = left ventricle; weight in grams). 
 
Figure 4.12 Linear regression analysis for Right ventricle MPI index values versus weight 
(n=290). 
(MPI=   myocardial performance index; RV = right ventricle: weight in grams) 
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Weight had little to no effect on the MPI for the 3 groups (Figure 4.11 and 4.12). The mean LV MPI was 0.30 
(Group 1: 0.31; Group 2: 0.29; Group 3: 0.29) and the mean for the RV MPI was 0.23 (Group 1: 0.23; Group 2: 
0.22; Group 3: 0.23). Left ventricle and right ventricle MPI values were compared and regression analysis 
showed that there was some correlation of these measurements (r = 0.63; Figure 4.13). There was no 
correlation (Figure 4. 14) between the MPI of the LV and the SF (r=0.24). 
 
 
Figure 4.13 MPI: Left ventricle versus right ventricle (n=290). 
(MPI = Myocardial performance index; RV = right ventricle, LV = left ventricle) 
 
 
Figure 4.14 Left ventricle MPI versus SF (n=290). 
(MPI:  Muscle performance index; LV = left ventricle, SF = Shortening fraction) 
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4.5 CARDIAC FINDINGS 
 
Clinically insignificant cardiac abnormalities were present in a large number of infants (Figure 4.15). The 
most common findings consisted of PDA’s (n=104; 36%) or PFO’s (n=96; 33%).  A total of 200 (69%) had 
both a PDA and PFO and the remainder of the infants (31%) had no cardiac lesions. PDA’s were present in 
26/44, 48/132 and 30/114 in groups I, II and III, respectively. Using the Fisher’s exact test, no difference 
were present in the prevalence of small PDA’s in SGA vs. AGA infants (p = 0.69). 
 
 
Figure 4.15 Cardiac findings  
(PDA = Patent ductus arteriosus ; PFO = Patent foramen ovale) 
 
4.6   LONGITUDINAL STUDY 
 
A longitudinal study was performed as a sub-objective. Fifteen preterm infants were investigated at different 
time intervals: 2-3 days after birth, 14 days and 28 days. All 14 cardiac dimensions (M-mode, 2-D and 
functional) measurements were calculated and manually plotted against the normative ranges as obtained 
from the study.  Cardiac dimensions increased parallel to weight gain for all the infants. Results showed that 
all the measurements from these 3 periods were within the upper and lower limits produced by the study for 
n=90; 31% 
n=96; 33% 
n=104; 36% 
none  
PFO 
PDA 
Cardiac Findings 
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all three weight groups (Fig.4.17-4.20). Plotted values are according to weight measured on the day of the 
cardiac echo and comp aired to the normative range of infants of comparable weight. 
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Figure 4.16 Weight gain 1-28 days 
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Figure 4.17 Aortic root diameter 1-28 days 
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Figure 4.18 Mitral valve annulus 1-28 days 
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Figure 4.19 Left ventricle end- diastolic diameter 1-28 days 
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Figure 4.20 Shortening fractions 1-28 days 
 
 
4.7 INTER-OBSERVER ERROR 
 
Before the study commenced, all echocardiographers attended a training session specifically aimed at 
measuring all dimensions according to the standardized ASE recommendations (Sahn et al., 1978). 
Immediately after this training, 10 infants’ cardiac dimensions were measured and one set of inter-observer 
data was produced. Retraining was given after two weeks and a second set of data (n = 15) was generated. 
Inter-observer error was calculated for all 3 Echocardiographers who participated in the study and 
calculated by the Bland and Altman method for the variability between scans. 
 
Table 4.31 depicts the differences in measurements between the first set of inter-observer analysis versus 
the second set. There were no statistically important differences between the observers  
(p <0.05). 
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TABLE 4.31 INTER-OBSERVER DIFFERENCES  
Variable 
Mean difference 
1st set 
(n=10) 
Mean difference 
2nd set 
(n=15) 
p-value  
for the 2nd set 
SF% 7.0 6.2 0.20 
LVEDD (mm) 1.7 0.6 0.98 
PW (mm) 1.1 0.4 0.99 
IVS (mm) 0.8 0.1 0.11 
LA (mm) 1.1 0.1 0.28 
AOR (mm) 1.6 0.7 0.69 
ACS (mm) 2.5 0.2 0.72 
LV MPI  0.22 0.25 0.36 
RV MPI  0.31 0.23 0.29 
(SF = shortening fraction; LVEDD = left ventricle end -diastolic diameter; PW = posterior wall; IVS = inter ventricular 
septum; LA = left atrium; AOR = aortic root; ACS = aortic cusps separation; LVMPI-= left ventricular myocardial 
performance index; RVMPI = right ventricular myocardial performance index) 
 
The LVEDD initially had an interobserver difference of 1.7 mm during the first measurements, but this 
improved after retraining by decreasing to only 0.6 mm. Similar observations were obtained for IVS (0.8 mm 
for the first set and 0.1 mm for the second).  The PW‘s first inter-observer value was 1.1 mm and for the 
second set 0.4 mm. 
 
None of the differences observed during the second set of measurements were statistically significant (p= 
<0.05).  The PW (1st-1.1, 2nd-0.4) and the IVS (1st-0.8, 2nd-0.1) showed the largest variations, but were not 
statistically significant. 
4.8   LOCAL VS. INTERNATIONAL VALUES  
 
The findings of this study were compared to International values.  Mean, sample size and standard deviations 
were compared and statistically analyzed. The majority of measurements were within the ranges of the 
international values for preterm and low birth weight infants.  Interestingly, when compared with Skelton et 
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al., (1998), significant differences were observed for diameters of the IVSd, PWd and LA across all weight 
groups with as well as the aortic root measurement in Group 1, were all of these measurements, measured 
larger than the international values (Table 4.32). 
TABLE 4.32 LOCAL VS. INTERNATIONAL VALUES A 
Variable 
 
GROUP 1 
 
Weight Category 
<0.999g 
 
GROUP 2 
 
Weight Category 
1000-1499g 
 
GROUP 3 
 
Weight Category 
1500-2500g 
Study 
data 
(n=290) 
(Skelton 
et al., 
1998) 
p value 
Study 
data 
(n=290) 
(Skelton 
et al., 
1998) 
p value 
Study 
data 
(n=290) 
(Skelton 
et al., 
1998) 
p value 
LVEDD 12.03 11.40 0.8770 12.45 12.30 0.9900 14.24 15.10 0.8300 
LVESD 7.86 7.80 0.8840 8.13 8.50 0.3970 9.30 11.50 0.5910 
PWd 3.18 2.60 0.0001 3.26 2.70 0.0001 3.58 2.70 0.0001 
IVSd 3.34 2.70 0.0001 3.33 2.80 0.0001 3.77 3.40 0.0100 
LA 8.76 7.90 0.0150 8.95 7.80 0.0180 10.85 9.50 0.0240 
AoR 6.85 6.50 0.0350 7.22 7.20 0.7800 8.26 8.40 0.2770 
(LVEDD= left ventricle end-diastolic diameter; LVESD= left ventricle end-systolic diameter; PW= posterior wall; IVS= 
interventricular septum; LA= left atrium; AoR= aortic root) 
 
When compared with, Walther et al., (1986) significant differences were observed for diameters of the LA, 
AO, IVSd, PWd and SF in weight groups 1 and 2 weight groups, and measured larger than the international 
values (Table 4. 33). 
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TABLE 4.33 LOCAL VS. INTERNATIONAL VALUES B 
Variable 
 
GROUP 1 
 
Weight Category 
750-1249g 
 
GROUP 2 
 
Weight Category 
1250-1749g 
 
GROUP 3 
 
Weight Category 
1750-2249g 
Study 
data 
(n=290) 
(Walther 
et al., 
1986) 
 
p value 
Study 
data 
(n=290) 
(Walther 
et al., 
1986) 
 
p value 
Study 
data 
(n=290) 
(Walther 
et al., 
1986) 
 
p value 
LVEDD 12.1 12.6 
0.2 
12.9 13.3 
0.17 
14.5 15.2 
0.08 
SD 2.1 1.5 1.9 1.2 2.1 1.5 
LVESD 7.9 8.5 
0.58 
8.5 9.1 
0.15 
9.4 9.8 
0.28 
SD 1.4 1.2 1.6 1.0 1.7 1.5 
SF% 34.5 33 
<0.007 
34.7 31 
<0.001 
35 36 
1.2 
SD 5.9 0.5 6.5 0.4 5.5 0.6 
IVSd 3.3 2.3 
<0.001 
3.4 2.6 
<0.001 
3.8 2.8 
0.03 
SD 0.6 1 0.7 0.8 0.7 0.8 
LA 8.7 7.2 
<0.001 
9.7 8.5 
<0.001 
11.0 9.6 
0.43 
SD 1.6 0.7 1.8 1 2.3 0.8 
AoR 6.8 6.3 
<0.005 
7.8 7.3 
<0.002 
8.2 8.4 
0.31 
SD 1.2 0.6 1.2 0.6 1.5 0.5 
PWd 3.3 2.1 
<0.001 
3.3 2.5 
<0.001 
3.6 2.6 
<0.001 
SD 0.7 0.6 0.6 0.7 0.8 0.6 
(LVEDD= left ventricle end-diastolic diameter; SD = Standard deviation; LVESD= left ventricle end-systolic diameter; SF% 
= shortening fraction; IVS= interventricular septum; LA= left atrium; AoR= aortic root) 
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Detailed measurements of cardiac structures remain a clinically important aspect to guarantee modern and 
scientific management of children with various types of congenital or acquired cardiac disease. Decisions 
regarding the type and timing of interventions, initiation and tailoring of pharmacological management often 
rely to a large extent on cardiac chamber measurements. For this  reason  the cardiac structures develop and 
grow with the child throughout childhood and interpretation of these measurements must take into account a 
patient’s body size or weight. 
 
Despite the importance of these measurements in practice, a comprehensive set of normative data in 
premature and low birth weight infants, derived from a large cohort of patients, are generally lacking. Some 
paediatric centres have developed their own reference normative data to use in their echocardiographic 
reporting and as a part of their clinical decision making. 
 
The use of echocardiography has also been expanded to include re-evaluation after surgery or initiation of 
oral or parenteral vasodilator therapy for pulmonary hypertension as well as re-evaluating withdrawal of 
extracorporeal cardiopulmonary support. It is also important in infants with respiratory distress where 
changes in the right and left heart dimensions occur.  Therefore the reliability and validity of these 
measurements are of great importance. 
 
Standardization of chamber measurements has been a problem since the early development of 
echocardiography. Dramatic changes in echocardiographic methods and techniques during the past ten years 
has improved imaging and strengthened its position as a dominant diagnostic instrument in cardiology in 
general (Lang et al., 2005). The preceding 15-20 years have introduced important developments in 
echocardiographic techniques, technology and resolution so that it is now possible to obtain more clearly 
identified M-mode waves and measurements. 
 
This study represents the first reported data for a sub-Saharan third world population. It establishes a 
comprehensive set of normative data. The study population included all the different race groups and 
especially a significant number of non-Caucasian patients who made up more than 90% of the sample.  It 
should be emphasized that the data of this sample reflects the Free State and Northern Cape population, but 
 CHAPTER 5 
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the author speculates that this data may be applicable to South Africa as a whole.  This study included two 
hundred and ninety preterm and low-birth weight infants (n = 290). Compared to previous international 
studies, this study is one of the largest and most recent. 
5.1   STUDY POPULATION  
 
Low birth weight is an increasing problem in both developed and developing countries. According to United 
Nations International Children’s Emergency fund (UNICEF), 22% of all low-birth weight infants born in 
developing countries are born in Africa. They state that the number of low- birth weight infants is more than 
double the number born in developed regions (UNICEF 2009:Online). Locally, low birth weight in South 
Africa is reported at a level of 14.6% for the private sector and this percentage increases to as much as 25% 
affecting dominantly the lower income groups of the public sector (Statistics South Africa 2011: Online).  
 
Although normative data is reported in the literature, a number of important differences should be noted. The 
majority of work has been performed in first world populations and this is one of the few studies 
representing third world populations. It is particularly noteworthy that this represents the only study in Sub 
Saharan Africa. A sub-objective was to determine whether differences in cardiac size are present in small for 
gestational age infants since little could be found in existing literature and as a result infants were also 
classified according to gestational age. The overwhelming majority of work in reported literature had been 
performed in term new-borns and only a limited number of studies were performed on exclusively 
premature infants or low-birth weight infants. Skelton and co-workers (1998) conducted a study 
consisting of 79 infants of less than 34 weeks gestation. Echocardiography was performed on days 0, 7 and 
28 after birth to produce a set of reference ranges. Cardiac dimensions correlated well with gestational age 
and birth weight. There was a significant increase in measurements over time as these infants gained weight.  
 
Sollinger et al., (1973) published a series of measurements which included preterm infants, all over 2750g in 
birth weight. Lange et al., (1983) reported a series of 91 premature infants, 49 of whom were less than 2500g 
in weight. Both studies included infants up to three weeks of age. Walther et al., (1986) also produced new 
reference ranges for the left heart and interventricular septum. Between them they examined over 300 
babies, but only between one and two thirds were preterm, and again very few were of low birth weight. In 
these studies- values were given in terms of birth weight but not gestation.  However, this research project 
included 290 preterm and low-birth weight infants, with a gestational age ranging from 26-40 weeks- with a 
median of 31 weeks. Of particular note, a large sample (n=44) of extremely low birth weight infants was 
included in the final cohort of patients whereas Skelton et al., (1998) only had 8 infants between 500-1000g.  
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Walther and colleagues (1986) investigated normative data on intracardiac dimensions and systolic time 
intervals in very low birth weight infants. M-mode echocardiograms were collected from 210 healthy preterm 
and term neonates with birth weights between 780 and 5,350g and gestational ages ranging from 26 to 43 
weeks.  
5.2   CARDIAC DIMENSIONS AND GENERAL CONCEPTS  
 
Overall, results of this study show that cardiac dimensions increased with an increase in body size/mass. LV 
dimensions, volumes, and wall thicknesses are echocardiographic measurements widely used in clinical 
practice and research. LV size and performance are still frequently visually estimated. However, qualitative 
assessment of LV size and function may have inter-observer variability and is a function of interpreter skill. 
Therefore, it should regularly be compared with quantitative measurements. Strict quality control for the 
proposed reference measurements was applied in this study. The American Society of Echocardiography has 
previously published standardized quantitative guidelines for chamber and vessel quantification during 
performance of a paediatric echocardiogram (Sahn et al., 1978). Because the sizes of cardiovascular 
structures increase with somatic growth, paediatric quantification requires the adjustment of measurements 
for the effects of body size in order to determine when a measurement is outside the normal range. A 
universal paediatric normative database of measurements from a normal population encompassing the full 
range of body sizes encountered in paediatrics would provide clinicians and researchers with a powerful tool 
to distinguish normal from abnormal values and too aid in the management of children with heart disease.  
 
It is important to highlight the fact that in this study all M-mode dimensions were calculated according to the 
American Society of Echocardiography’s (ASE) standards.  Reported literature rarely states whether 
accepted, standardized criteria were used during conducting of studies. Few other studies used standardized 
published criteria (Kampman et al., 2000 and Guzeltas et al., 2011) but their studies were carried out in term 
infants. This emphasizes the lack of standardized, repeatable measurements. Moreover, the majority of 
previously published work is all over ten years old and most did not specify that they used the ASE method or 
did not make use of this standardised method of measuring. Rapid technological advances have been seen 
over the past decade; it is important to realize that equipment has shown marked refinement since the early 
80’s. All these factors combined gave rise to a considerable improvement in the quality of scanning.  It is thus 
logical to reason that modern echocardiography equipment will thus enable more refined and accurate 
measurements, especially of tiny morphological structures in a small hyper mobile heart. 
Cardiac dimensions have been expressed as a percentage of the mean normal value, but this does not take 
into account normal variation. Another commonly used method for expressing normal values is the use of 
percentile charts. Although these are useful for determining whether a given value lies within the population, 
values that lie above or below the uppermost or lowermost percentile lines, respectively, cannot be 
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quantified. This limitation is overcome by the use of z-scores (i.e. the number of standard deviations a 
measurement departs from the normal mean). The use of z-scores enables a more precise assessment of 
cardiac measurements, which is particularly important in conditions associated with very small chamber 
dimensions (e.g. hypoplastic left heart syndrome, pulmonary atresia) or very large measurements (e.g. wall 
thickness in hypertrophic cardiomyopathy). In this study, upper and lower limits were established for all 
variables (z-2 and z+2).  A separate table for easy clinical reference with upper and lower limits were thus 
developed. We expect to use this in neonatal units as a quick reference guide.  A cut-off value of z-3 was 
included for rapid determination of hypoplastic left hearts as the ultimate cut-off point for any intervention in 
clinical practice. 
5.2.1 TWO- DIMENSIONAL MEASUREMENTS 
 
To our knowledge there are no other studies available for mitral and tricuspid valve annular measurements 
in premature and low birth weight infants. This parameter is especially important in congenital heart lesions 
where cardiac structures are underdeveloped affecting especially the left heart such as hypoplastic left heart, 
congenital mitral stenosis as well as for the right heart with lesions such as pulmonary atresia, tricuspid 
atresia and tricuspid stenosis. Quick reference values including values for z+3 and z-3 were also developed in 
the study for these in order to be used for selection for palliative or reparative surgery when dealing with 
these very small infants. 
5.2.2 FUNCTIONAL MEASUREMENTS  
 
As expected standard M-mode functional measurements (SF, EF) remained constant for all weight groups. 
The shortening fraction is most often used to determine left ventricular function, especially in newborns. 
Since it is relatively independent of changes in heart rate- (therefore ideal in newborns which usually have 
very high heart rates), or loading conditions of the heart, it is independent of preload/afterload. 
 
The Myocardial Performance Index (MPI) has the advantage that it is simple, non-invasive, easy to estimate 
and is reproducible. The index combines systolic and diastolic function and can thus be viewed to represent 
global heart function. It is a combination of systolic and diastolic time intervals based on ejection time, 
relaxation period and contractility. It has been shown to be reliable and reproducible and in clinical practice it 
could be viewed as a rough indication of global cardiac function, comparable to erythrocyte sedimentation 
rate for infection. However, as a measurement, it is independent of ventricular geometry, heart rate, 
atrioventricular valve regurgitation, afterload and preload conditions. Limitations of the MPI include the fact 
that measurements are obtained during two different cardiac cycles. One should not overlook the fact that a 
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pseudo normalization phenomenon occurs when the shortening of the IVRT due to both systolic and diastolic 
dysfunction lowers the MPI index under certain conditions, resulting in less accurate estimation of cardiac 
function. Therefore, in this study, five cardiac cycles were measured and averaged to compensate for external 
influences.  
 
In this study the MPI index values for the right ventricles were overall 0.23 and for the left ventricle 0.30. The 
right ventricle was slightly lower than the left ventricle indicating a more forceful right ventricular function. 
One can anticipate this since the right ventricle is more dominant during fetal life. The fact that the results 
show that the two MPI values correlate well indicates that the left ventricle and right ventricle developed in 
parallel postnatally. 
5.3 COMPARISONS 
5.3.1. GENDER 
 
The results of this study showed that gender did not have any effect on cardiac dimensions or function. In 
contrast to our findings gender differences have been reported in some studies (Kampman et al., 2000). 
However the population consisted mostly of older children – a finding most likely linked to the hormonal 
influences during puberty (Kampman et al., 2000).  But for these young low birth weight infants in the Free 
State and Northern Cape, gender has no influence on cardiac dimensions. Our findings are in agreement with 
similar results of Kampman et al., (2000) who conducted a study  on 2036 children in an age group ranging 
from one day to 18 years of age and Guzeltas et al., (2011) in a study consisting of 250 newborn infants, 
weighing between 2000-4500g, who also found no significant differences between the genders.  A limited 
number of previous studies have shown that measurements were either not or only minimally influenced by 
sex differences in these small infants and that hormonal influences only start playing a role during puberty 
(Henry, Ware, Gardi, Hepner, McKay & Weiner, 1974).  
 
 
 
 
5.3.2. SGA, AGA, WEIGHT AND BSA 
 
A particularly noteworthy and clinically significant finding is that weight and body surface area (BSA) are 
closely related and can be used interchangeably. As a matter of fact, there was an excellent correlation 
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(r=0.98) between BSA and birth weight for all measurements. Roge et al., (1978) also tested these 
correlations and found that in fact, each of the variables (height, weight, BSA, and cube root of weight) were 
so strongly correlated with one another (r>0.90) that regression using any one of the four as independent 
variables were equivalent for all practical purposes.  This finding has a number of important clinical 
applications. Weight is much quicker and easier to perform on a standardized scale opposed to body surface 
which is a calculated value consisting of weight and length. Weight is also more likely to be accurate and can 
be performed by anybody after minimal training on a digital scale. In units of the Free State and Northern 
Cape weight is a standard measurement available in all documents related to newborns and thus freely 
available to any physician doing cardiac interrogation. 
 
Limited data exist comparing cardiac dimensions between AGA and SGA infants. The good correlation 
between weight and BSA was also present when the two groups were compared and also an important 
finding to take note of.  Cardiac dimension and function of SGA and AGA infants were separately analysed but 
statistical analysis demonstrated that no significant differences in cardiac dimensions of functional 
measurements existed for comparable weight and BSA. 
 
This is interesting, since we expected AGA to be slightly larger than those of SGA infants whose 
measurements we speculated could be influenced by the long periods of intrauterine growth retardation. SGA 
infants are usually taller and thinner and it could be speculated that their cardiac development may thus also 
differ. However, the results show that there were no differences in cardiac contractility or in the size of 
cardiac dimensions. This is supported by the fact that the study groups’ cardiac measurements remained the 
same whether it was compared or plotted against BSA or weight. As a result, the investigator thus opted to 
plot the values against weight due to the fact that weight has less probability of mathematical error if used 
rather than BSA and is also much easier and less time consuming to determine.  To conclude, there is no 
significant difference between BSA and weight in all low-birth weight preterm infants and this can also be 
extended to SGA infants. It is therefore not necessary to develop separate tables for cardiac dimensions for 
SGA infants. This is supported by international studies that have reported that the cardiac dimensions for SGA 
fetuses can be smaller or greater than AGA infants but are not significantly different (Goldenberg et al., 2008). 
 
Henry et al., (1974) found that M-mode echocardiographic measurements in infants and children up to early 
adulthood followed a linear regression either directly related to the body surface area or its square root. Also, 
Epstein, Goldenberg, Allen, Konecke & Wood (1975) referenced their data solely to BSA. They found that, in 
small children and infants, BSA correlated poorly as a result of wide variations in height. Henry and co-
workers (1974) pointed out the importance of considering age as well as BSA or weight in normal predicting 
equations. Thus there was not complete agreement on the best reference point for reporting normal data.  
Therefore, after the analysis of this data, only one set of reference values was developed to make it clinically 
useful and applicable for general use as a quick reference guide. 
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A study conducted by Leipala, Boldt, Turpeinen, Vuolteenaho and Fellman (2009) found that fetal growth 
restriction is associated with alterations in early hemodynamic adaptation in low birth weight infants. 
Increased ventricular output and cardiac hypertrophy occur in fetal animals in chronic anaemia and hypoxia. 
The septal and left ventricular hypertrophy observed in the infants could be explained by increased left 
ventricular work load in utero resulting from the shift in the left to right output ratio (Leipala et al., 2009). 
The authors speculated that another possible explanation for an increase in left ventricular afterload is 
impaired systemic vascular resistance. Low birth weight has been reported to be linked with decreased 
endothelium –dependant vascular dilatation later in life (Leipala et al., 2009). Cardiac hypertrophy observed 
in the infants is in accordance with previously reported hypertrophy of both ventricles in growth – retarded 
foetuses. The most probable mechanism of this hypertrophy is prolonged exposure to an increase in 
myocardial workload (Leipala et al., 2009). In this study however, no differences could be found between SGA 
and AGA infants to validate these findings. 
 
In summary, the data provided evidence for the importance of weight and BSA as predictors of cardiac size 
and function in all types of low birth weight infants and are applicable to small and normal for gestational age 
infants. Due to the strong correlation between weight and BSA we preferred body weight to standardize the 
M-mode echocardiographic measurements in our population. In newborns, because of the small body surface 
area, body weight was preferred for accuracy of measurements. This is further supported by the work of 
Guzeltas et al., (2011) which also revealed a good correlation with body weight. When body weight increased, 
the measured values also increased in parallel. The measured values were not influenced by gender. 
Functional parameters did not change with body weight and gender. 
5.3.3 LONGITUDINAL STUDY 
 
The infants in the longitudinal study showed, as expected, an increase in body mass and surface area over the 
28 day period. Parallel increases in cardiac dimensions were seen over time as the infants developed and 
gained small amounts of weight.  All the cardiac dimensions and functional indices however, when plotted 
against body weight of the main group, remained within the upper and lower limits found in the study.  No 
obvious changes were observed in ejection fraction, shortening fraction or MPI index. Similar findings have 
been well documented in term and older infants. The data obtained from the longitudinal arm of this study 
thus illustrates that our reference ranges can be applied to all LBW infants with gestational ages ranging from 
1-28 days.  
 
The longitudinal study is particularly noteworthy. Some infants were re-measured at different ages up to 28 
days. In these, body weight at the time of echocardiographic analysis was performed and the cardiac 
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dimensions compared to infants in the same weight group (as determined by the study) as the infant at the 
time of measurement. All these measurements from 0 – 28 days were within the normal ranges for weight as 
determined by the study. Cardiac dimensions increased parallel to increase in body weight. This has 
important clinical implications: it would seem to indicate that the reference ranges can be used for low birth 
weight infants from 0 -28 days. This is supported by a number of other studies. Skelton et al., (1998) found a 
close correlation of gestational age and birthweight and concluded that either can be used for reference 
ranges. Zecca, Romagnoli, Vento, De Carolis, De Rosa and Tortorolo (2001)  longitudinal study did not find the 
same correlation with gestational age, but demonstrated that dimensions increase parallel to increase in body 
weight. This was also shown by Walther et al., (1986). Results of the longitudinal study showed that increase 
in body weight is closely correlated with an increase in cardiac diameter and that as an infant ages and gains 
weight, cardiac dimensions increase in parallel. We therefore conclude that, based on the fact that all 
measurements between 1 - 28 days were within z -2 and +2 when analysed for weight at the time of 
measurement, the reference ranges as determined for weight can be used for all low birthweight infants 
between 1 - 28 days of age and that body weight, rather than gestational age is an important determinant of 
cardiac dimensions. 
 
5.3.4 LOCAL VERSUS INTERNATIONAL VALUES 
 
The sample size of this study is larger than other studies performed on low birth weight and premature 
infants. The study included 290 infants and also included functional assessment of the LV and the RV together 
with M-mode measurements. Skelton et al., (1998) only included 79 infants but had the largest sample for 
preterm infants and it is the most recent reference values for cardiac dimensions. Walther and colleagues 
(1986) investigated normative data on intracardiac dimensions and systolic time intervals in very low birth 
weight infants. M-mode echocardiograms were collected from 210 healthy preterm and term neonates with 
birth weights between 780 and 5,350g and gestational ages ranging from 26 to 43 weeks. 
 
The investigator intended to compare our local values with the “golden standard” as proposed by Roge, 
Silverman, and Hart & Ray, 1978.  However, this study only consisted of 93 patients, infants and children up 
to 18 years of age. The exact numbers of premature infants were not stated by the authors. On closer 
inspection of the original study, it became clear that the dimensions for BSA were extrapolated where data 
was not available. The nomograms for cardiac dimensions according to BSA are also difficult to read for 
patients with low/small body surface areas. The data was compiled in 1978 and we thus resorted to more 
recent and comparable work. 
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When compared with Skelton et al., (1998) and Walther et al., (1986) the investigated overall values were 
very similar although minor but statistically significant differences existed.  
When compared with Skelton et al., (1998) significant differences were found in the measurements for the 
PWd, IVSd and LA, with our measurements measuring statistically larger. Possible explanations for these 
findings include the fact that the IVS and PW are very small muscular structures and with the improvement in 
scanning equipment and transducers to measure these fine structures, outlines become more clearly visible 
and thus more accurate measurements can be obtained. Alternatively, it could be due to the fact that this 
sample size is much larger than Skelton et al., (1998) and the study has more accurate measurements due to 
the larger sample size. 
 
When compared with Walther et al., (1986) significant differences were also observed for the diameters of 
the LA, AO, IVSd, PWd and SF across weight groups.  Note should be taken that our weight categories were 
different to that of Walther et al., (1986) but we reanalysed and re-arranged our data into similar weight 
categories to ensure comparable data. It may be that the weight categories may have had an effect on the 
dimensions, although it is highly unlikely, since similar significant differences were observed when compared 
to the Skelton et al., (1998) data as mentioned. The fact that similar differences were observed between this 
comparison as well as those of Skelton et al., (1998) highlights the fact that regional differences may exist. 
 
Additional explanations for these variations could be explained on the basis of ethnical and racial differences. 
One could speculate that this difference could thus be a racial or regional difference and that the average 
African infants’ septum and posterior wall might be thicker than the average European infant’s. Alternatively, 
the inclusion of SGA infants may have had some influence on the results, but PWd and IVSd were compared 
for AGA and SGA infants and no significant difference in thicknesses were observed. We did not record IVSs 
and PWs, which should become even denser in systole, and this may be a focus for future studies. The 
presence of “physiological” hypertrophy is important for neonatologists to take note of since certain drugs 
(e.g. steroids) may induce hypertrophy and if international ranges are used, infants may incorrectly be 
considered to have secondary cardiac effects of these drugs. 
 
This highlights why it is so important to develop normative values for specific populations. The majority of 
African infants are more likely to battle with high blood pressure and left ventricle hypertrophy in their 
adulthood and this inclination towards left ventricular hypertrophy may even start in infanthood. Cardiac 
dimensions of preterm babies differ from those seen in older children and adolescents and it is important to 
know these for a given population in order to accurately evaluate measurements in sick children. 
 
The left atrial diameters also measured larger than Skelton et al., (1998) and Walther et al., (1986) averages 
for all weight groups. It is difficult to explain but, from a physiological perspective, one can speculate that it 
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might be due to the fact that the posterior wall and interventricular septum is thicker, and thus maybe less 
complaint in diastole. This can lead to a more dilated LA in order to handle retrograde pressure.  
 
Another important factor regarding LA size is that it is used to determine the size and effect of the PDA on the 
left heart and all left to right shunt abnormalities like a ventricle septal defect (VSD).  The LA is an important 
indicator of how well the pulmonary system and systemic system is functioning.  The aortic root: LA ratio 
gives an indication regarding the size of the PDA.  It should be noted that we included infants with small 
PDA’s (haemodynamically significant PDA’s were excluded – Chapter 3: Methodology (Section: 3.3.1 In and 
Exclusion Criteria, pg 33) and another explanation may therefore be the presence of ductuses in a third of the 
study population which may give rise to the slightly larger LA sizes. However, in the Skelton et al., (1998) 
study only “congenital heart lesions other than PDA” were excluded, which would indicate that even large 
PDA’s may have been included.  In the Walther et al., (1986) study the only reference to exclusion criteria 
were “clinical or radiological evidence of cardiovascular abnormalities” and they only looked for PDA when 
LA/Ao ratio were > 1.25 while in the Silverman (1993) studies, PDA’s were not even mentioned. We therefore 
included these silent PDA’s since it represents a true reflection of “normal” and theoretically should yield real 
life clinically relevant reference values. 
 
This result would thus seem to indicate that the LA may be naturally larger in African infants and this ratio 
needs to be adapted before the size of the PDA or any other congenital abnormality affecting the left heart and 
its effects can be evaluated in our population. In this study - the LA /aortic root ratio was calculated and the 
results were as follow: Group 1(1.27:1), Group 2(1.23:1) and Group 3(1.31:1), compared to Walther and 
colleagues (1986) with a ration of (1.16 +/- 0.10). The fact that minor PDA’s were included support the 
conclusion that a LA/Ao root ratio of ≤ 1.3 is unlikely to be of any haemodynamic significance in our 
population. 
 
Regarding MPI index values, in a study by Eidem, O’Leary, Tei, and Seward (2000) they found the RV MPI in 
152 normal children (ages 3-18 years) to be 0.32  0.03 this is slightly higher than our mean for LV MPI:  0.30 
(Group 1: 0.31; Group 2: 0.29; Group 3: 0.29) and RV MPI 0.23 (Group 1: 0.23; Group 2: 0.22; Group 3: 0.23). 
In another study by Tsutsumi, Masahiro, Eto, Hota, and Kato (2002), the MPI index was prospectively and 
longitudinally determined in 50 normal foetuses. The MPI index of the left ventricle decreased linearly with 
advancing gestational age during 18-33 weeks and decreased more rapidly with increasing gestational age 
after 34 weeks (LV MPI- 0.43 +_0.03). The index of the right ventricle decreased slightly and linearly with 
advancing gestational age during 18-41 weeks (0.49+_ 0.05). In neonates, the MPI index of the left and right 
ventricle increased immediately and transitorily after birth and decreased and stabilized after 24 hours of 
life.  Considering most of the infants in our study was seen 72-96h after birth- our values correlate well with 
theirs given for that time frame (LV MPI- 0.38, RV MPI- 0.28). 
 
Chapter 5 / Discussion   83 
 
5.3.5 INTER-OBSERVER VARIABILITY 
 
Only a few studies have taken inter-observer variability into account when producing normative values. 
Before the study commenced all echocardiographers were trained to measure all dimensions according to the 
standardized ASE methods (Sahn et al., 1978). After this training, 15 infants’ cardiac dimensions were 
measured and one set of inter-observer data was produced, evaluated and differences inspected. Inaccuracies 
in measurements were addressed and a second set of data after re-training was produced. The second set 
showed little to no differences between the observers. The study then proceeded. Therefore, the data 
collected during the whole study period was accurate and reproducible because a systematic method was 
followed. This ensured qualitative control and reliability of all measurements.  
Results from other studies looking at intra-observer and inter-observer variations of echocardiographic 
measurements are limited, especially in children. Previous studies on inter-observer variation of 
echocardiographic measurements have shown different results. Most studies varied within the limits of 10% 
which is generally considered clinically insignificant (Shifan, Ayres, Harris, Bricker & Labarthe, 1999; Sahn, 
DeMaria, Kisslo, and Weyman, 1987).  In this study the interobserver variations also fell bellow the limits of 
10% which is found to be non significant in the clinical measurements. 
5.4 STUDY LIMITATIONS  
 
Although thorough scientific rules and methods were employed in the execution of this study it is important 
to take note of the limitations that might affect the results of this study. The infants in this study were not 
randomly selected since the study wanted to look at the profile of infants who had no cardiac abnormalities 
and who met the inclusion criteria. Although the study aimed to include a minimum of 50 infants in a weight 
group- only 44 very low – birth weight infants were included in group 1: (<0.999g).  However, this is still the 
largest amount of these small infants of this weight group in an echocardiographic study. Cross sectional 
studies are relatively quick and easy to perform but do not permit distinction between cause and effect.  
Another limitation is the fact that the study did not record IVS and PW in both systole and in diastole, the 
study only measured in diastole. We also did not analyse the IVS/LVPW ratio in the groups to determine the 
presence of asymmetrical hypertrophy for the reason that the aim was to yield a set of normal reference 
ranges. It would have been helpful to record blood pressures in our study population to compare with 
international data, but this was primarily an echocardiographic analysis. 
 
The study had more than 2 investigators which could have influenced the quality of the measurements but 
this was compensated for by evaluating interobserver variation which showed no statistically important 
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differences. Further studies need to be carried out to explore possible causes for difference in sizes of cardiac 
walls in systole especially in very low birth weight infants. 
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The strength of this study lies in the fact that it is a first for Africa. Although the sample consisted of mostly 
children of the Free State and Northern Cape, the study reflects our population as a whole. 
It is also one of the largest and most recent series on low-birth weight and preterm infants worldwide. 
 
It is the first study that provides normative data for cardiac measurements of low birth weight infants for 
South Africa. The study data is accurate and reproducible, interobserver analysis was performed and 
monitored to improve the accuracy of the measurements. The study assessed normative cardiac 
measurements divided in M-mode, 2-D and functional measurement for premature infants in 3 weight 
groups.   
 
The study developed normative ranges for cardiac measurements for the Free State and for use in South 
Africa. The study values differ slightly from the international values.  
 
Weight correlated well with BSA and the data suggest that weight can be used to develop tables for clinical 
use. Cardiac chambers increased with BSA and weight and functional measurements stayed the same 
throughout the weight groups. Gender and race played no role in any functional measurements or with the 
cardiac sizes. 
 
There were also no differences between Average for gestational age (AGA) and Small for gestational age 
(SGA) infants in this study group- therefore indicating the development of only one set of reference range 
values for both SGA and AGA infants.  
 
The longitudinal study also confirmed that the values are applicable to all low birth weight infants up to 28 
days of age.  
 
The average South African infant’s cardiac chambers differ in some from international values. The IVS and PW 
measured thicker and the LA larger. This could be due to numerous factors that should be investigated 
further. It also support the fact that population specific reference values should be developed and used. 
Systolic and global functions were remarkably similar and constant throughout weight categories. 
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In conclusion- the study emphasised the profound effect of growth and weight gain on the cardiac structure 
and the importance of measuring these structures according to a standardized specified protocol (ASE).  
Normative values are a useful and effective tool in children for assessing the effects of medical therapy on the 
severity of valvular regurgitation and on ventricular compensation and function when it might change 
medical management.  Also in assessing patients with known cardiac defects to determine the timing of 
medical or surgical therapy and assessing suspected cardiomyopathy, heart failure, and changes in clinical 
status or to guide medical therapy. It is also important in the screening patients for genetically transmitted 
cardiovascular disease, such as cardiomyopathy, Marfan syndrome, or Ehlers-Danlos syndrome and for 
conducting baseline evaluation and re-evaluation of patients receiving cardio toxic chemotherapy to 
determine the advisability of additional or increased dosages.  
 
RECOMMENDATION 
 
Future aims should focus on constructing studies to monitor possible causes for the increase in IVS, LA, and 
PW sizes. Further studies could also be aimed at the follow up of these infants to see whether with aging- the 
septum and posterior walls increase or decrease in size or normalizes.
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TOESTEMMING TOT DEELNAME IN 
NAVORSING 
 
ST U DIE:   VER WY SINGS VA N HART SONA R  WAA R DES VI R  P REMAT UR E EN  
P A SGEBORE BA BA S VIR   DIE  VR Y ST AA T  EN NOOR D KA AP  
Studie Dokter Naam:  Prof. SC Brown, Dr DG Buys, S.Jacobs 
U is ingelig oor die studie deur: 
Hiermee word u gevra om deel te neem aan ‘n navorsings studie.Let daarop dat as u hierdie vorm 
voltooi, u vrywilllig instem om deel te neem aan die navorsings projek. U sal anoniem bly en u data 
sal as konfidensieel behandel word ten alle tye.U mag u kind onttrek van hierdie studie op enige 
oomblik gedurende die voltooiing van die vorm/ prosedure. 
Die doel van hierdie studie is om inligting te versamel so dat pasiënte soos u kind  en ander in die 
toekoms meer akkurate, vinnige, en effektiewe gesondheidsorg en behandeling kan ontvang. Dit sal 
ook die mediese wetenskap bevoordeel en nuwe inligting verskaf aan gesondheidspersoneel.  
Let daarop dat geen vergoeding vir u deelname beskikbaar/betrokke is nie.U mag Prof S.C 
Brown/S.Jacobs skakel indien u enige navraag het in verband met die studie. 
U mag die Etiek kommitee skakel by die Fakulteit van Gesondheidswetenskappe OFS, by (051) 
4052812 indien u enige navraag het. 
U deelname aan die navorsing is vrywillig en u sal nie gepenaliseer word of verlies lei indien u 
deelname weier nie. 
Daar is geen risiko verbonde aan Eggokardiografie nie en dit is suiwer diagnosties van aard.  
Let wel: Hierdie is nie ‘n volledige hartsonar nie,indien enige abnormaliteite gevind word,sal dit aan 
‘n Kardioloog gerapporteer word,wat dan verdere ondersoek sal instel. 
U herken hiermee dat die bogenoemde inligting verbaal aan u oorgedra is. Ek verstaan my 
betrokkenheid in hierdie studie en neem vrywillig deel.
  HANDTEKENING VAN 
OUER/VOOG: 
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INFORMASIE DOKUMENT 
  
Studie titel: 
Verwysings van hartsonar waardes vir premature en pasgebore babas vir die Vrystaat en 
Noord Kaap 
 
Dankie vir u deelname aan hierdie vrywillige studie. 
Voorwoord: 
 
Ons, die Department van Pediatriese Kardiologie is tans besig met navorsing om normale waardes 
van eggokardiografie te bepaal op kinders in die Vrystaat en Noord-Kaap provinsie. 
Uitnodiging om deel te neem: Ons vra u toestemming om u kind in die studie in te sluit.  
 
Wat is in die studie ingesluit – Die studie bestaan uit ‘n roetine hart sonar wat gedoen sal word 
deur ‘n gekwallifiseerde eggokardiograaf ten minste een keer gedurende die studie periode. Die toets 
prosedure neem ongeveer 10 minute en is nie pynlik nie. Die hart sonar sal by u kind se saal gedoen 
word. Ons beoog om sowat 500 kinders in die studie te gebruik en ons sal u ondersteuning 
waardeur. 
Risiko’s om deel te neem aan die studie: Die mediese wetenskap is tans nie bewus van enige 
risiko’s wat met  roetine eggokardiografie gepaard gaan nie.  
Voordele om deel te wees van hierdie studie: U kind se hart se grootte en funksies sal geevalueer 
word en afmetings sal geneem word,enige abnormaliteite  sal ook gerapporteer word aan ’n 
Kardioloog 
Deelname is vrywillig, en om te weier om aan die studie deel te neem, sal geen nadeel aan die 
pasiënt wees nie. Die pasiënt mag ten enige tyd onttrek vanaf die studie sonder om enige voordele te 
verloor. 
Konfidensialiteit: Moeite sal gedoen word om alle informasie persoonlik en vertroulik te hou. 
Absolute konfidensialiteit kan egter nie gewaarborg word nie. Die Etiese kommitee mag deel van die 
studie gebruik vir mediese navorsing. 
Kontak besonderhede van navorsers : 
Mej. S.Jacobs, Dr. DG Buys Departement Pediatriese Kardiologie; tel: 051 405 3302 
Prof S C Brown,  Departement van Pediatriese Kardiologie; tel: 051 405 3241 
U mag ook die Etiese kommitee skakel by die Fakulteit van Gesondheidswetenskappe by (051) 
4052812, indien u enige navrae het in verband met die navorsingsprojek. 
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INFORMATION DOCUMENT 
Study title: Reference Echocardiographic measurements for premature and newborn infants of the 
Free State & Northern Cape 
Introduction: 
We, the department of Paediatric Cardiology are doing research on the size and function of the heart 
chambers in all newborn infants.  Research is just the process to learn the answer to a question.  In this 
study we want to learn what the normal size of cardiac chambers are for children in central South Africa. 
Invitation to participate:  We are asking for your permission to include your child in this research study. 
What is involved in the study: the study consists of routine heart sonar being done by qualified 
echocardiographers at least once during the period of the trial. An examination lasts about 10 minutes 
and is not painful. This will be done on your baby in his/her bed and the infant will not have to be moved 
anywhere. We intend to study at least 500 infants in this study and shall appreciate your support to help 
our children.  
Risks: Science is currently not aware of any risks involved in routine echocardiography. This is also not 
painful and presents no discomfort for the children. 
Benefits of being in the study: 
 Firstly you will assist us to determine normal values for children of central South Africa and help us to 
treat them better in future; secondly, if any abnormality is detected, your treating physician will 
immediately be notified and he will be able to arrange correct management. 
Participation is voluntary, and refusal to participate will involve no penalty or loss of benefits to which 
the subject is otherwise entitled; the subject may discontinue participation at any time without penalty or 
loss of benefits to which the subject is otherwise entitled.  
There are no costs involved for you or your child. 
Confidentiality:  Efforts will be made to keep personal information confidential.  Absolute confidentiality 
cannot be guaranteed.  Personal information may be disclosed if required by law. 
Organizations that may inspect and/or copy your research records for quality assurance and data 
analysis include groups such as the Ethics Committee for Medical Research and the Medicines Control 
Council (where appropriate). 
If results are published, this may lead to individual/cohort identification.  
Contact details of researcher(s) – for further information/reporting of study-related adverse events.  
Prof S C Brown, Department of Pediatric Cardiology; tel: 051 405 3241 
You may also contact the Secretariat of the Ethics Committee of the Faculty of Health Sciences, UFS at 
telephone number (051) 4052812 if you have questions about your rights as a research subjec 
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CONSENT TO PARTICIPATE IN RESEARCH 
 
You have been asked to participate in a research study. 
You have been informed about the study by ………………………………………. . 
You may contact department Paediatric Cardiology at 051 405 3241 any time if you have questions about 
the research. 
You may contact the Secretariat of the Ethics Committee of the Faculty of Health Sciences, UFS at 
telephone number (051) 4052812 if you have questions about your rights as a research subject. 
Your participation in this research is voluntary, and you will not be penalized or lose benefits if you refuse 
to participate or decide to terminate participation. 
If you agree to participate you will be given a participant information sheet, which is a written summary 
of the research. 
The research study, including the above information has been verbally described to me.  I understand 
what my involvement in the study means and I voluntarily agree to participate.  
 
_____________________    
Signature of Participant   Date 
 
 
_____________________    
Signature of Witness   Date 
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TUMELLO HO NKA KAROLO DIPALOPALONG 
 
THUTO: HO LEKALEKANYA DIPALO TSE TLWAELEHILENG TSA SONAR/ECHO BANENG BA HLAHILENG 
PELE HO NAKO. 
 
O kopilwe ho  nka karolo thutong ya dipalopalo. 
O tsebisitswe ka thuto ena ke ………………………………………. . 
 
Tseba hore ha ho na hlapiso ya chelete e tla bang teng. 
O ka letsetsa Prof SC Brown ho 405 3241 nakonngwe le nngwe, ha o naledipotso mabapi le patlisiso ena, 
kapa ha patlisiso ena e o thefula. 
O ka letsetsa mongodi wa Komiti ya Ethics (molao o laolang) ya lefapha la saense ya tsa bophelo ya 
Yunivesithi ya Foreisetata mohaleng ona 051-405 2812, ha o na le dipotso ka ditokelo tsa hao ha o nka 
karolo dipalopalong. 
Ha o dumela ho nka karolo, o tla fiwa setshoano (copy) sa tokomane ena, le pampiri e ngotsweng e hlalosa 
tsohle ka monka karolo, e hlalosang ka bokhutshwane ka patlisiso. 
Thuto ya patlisiso, le hlaloso e ka hodimo, ke e hlaloseditswe. 
 
Ke ya dumela honka karolo thutong ena, ho bolela hore ke dumela ntle le qhobello ho nka karolo. 
 
_____________________    
 
 
Tekeno ya monka karolo   Letsatsi 
 
 
_____________________    
Tekeno ya Paki    Letsatsi 
(Ha ho hlokahala) 
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TOKOMANE YA HLALOSO 
Sehloho sa thuto: Ho lekalekanya dipalo tse tlwaelehileng tsa M-mode le Doppler echo (sonar) baneng 
ba hlahileng pele ho nako. 
Re lebohela ho nka karolo ha hao thutong ena e sa qhobellweng. 
Tsebiso: Rona, lefapha la Pediatric Cardiology, re etsa patlisiso ya boholo bo tlwaelehileng ba dipelo 
baneng ba hlahileng pele ho nako Profinsing ya Foreistata. Patlisiso ka tsela ya ho fumana karabo 
potsong. Thuto ena, re batla ho tseba boholo bo tlwaelehileng ba dipelo le hore di sebetsa jwang baneng 
ba mona ha rona, hobane ha jwale re sebetsa ho ya ka ditekanyo tsa bana ba mafatshe a mang, tse nako 
nngwe di sa lekalekaneng. Le ha ese patlisisiso e tlwaelehileng baneng ba hlahileng pele ho nako, diteko 
tse ngata di etswa tsatsi le letsatsi baneng ba hlahileng pele ho nako, tse kenyeletsang dipatlisiso tseo re 
ikemiseditseng ho di etsa. 
Taletso ho nka kanolo: Re kopa tumello ya hao to Kenya ngwana wa hao patlisisong ena. 
Ho kenyeletswang thutong ena: Thuto e kenyeletsa sonar e tlwaelehileng, e etswa ke motho ya 
phethilengdithuto tsa sonar, bonyane hangwe nakong ya patlisiso ena. Teko e nka metsotso e ka bang 10, 
ha e bohloko. E etswa ngwana wa hao a robetse betheng ya hae, ebile ha ho moo a tlwa iswa teng. Re 
ikemiseditse ho sheba bana ba ka ba 50 ho qaleng ha thuto ena. Re tla thabelo tshehetso ya hao ho thusa 
bana ba rona. 
Bothata ba ho kena thutong ena: Saense ha ena bopaki ba bothata bo ka bakwang ke sonar e 
tlwaelehileng. 
Molemo wa ho kena thutong ena: Pelo ya ngwana wa hao e tla shejwa hore ha ena phoso, ka jwalo e tla 
thusa nakong e tlang ha mohlomong ho ka ba le ngwana ya nang le pelo e tshwanang le ya hae, ho e 
lekalekanya le yone. 
Ho nka karolo ha ho qhobellwe: E bile ha o hana ho nka karolo ha o na ho ahlolwa, kapa wa tingwa 
menyetla e mohlomong e o tshwanetseng; monka karolo a ka tlohela nako nngwe le nngwe ntle le ho 
lahlehelwa ke menyetla e mo tshwanetseng. 
Sephiri: Ho tla etswa matsapa hore boitsibitso ba hao ebe sephiri. Sephiri se felletseng ha se na ho 
hlapanyetswa. Boitsibiso ha hao boka nna ba ntshiwa ha bo batlwa ke molao. 
Mekgatlo e ka kopisang/shebisisa kapa ho kopisa patlisiso ena ho sheba hore e entswe ka makgethe e 
kenyeletsa dikopano tse kang komiti ya Ethics ya dipatlisiso tsa Bongaka. 
Ha diphetho di phahlalatswa, ho ka hlaha boitsibiso ba batho/bana ba itseng. 
Ho iteyanya le ya etsang dipatlisiso – 
Prof S C Brown, Dr.DG Buys, Miss S Jacobs  
Lefapha Pediatric Cardiology; Mohala: 051 405 3241 
O ka iteyanya le mongodi wa Komiti ya Ethics ya lefapha la Saense ya tsa bophelo, Yunivesithi ya 
Foreistata nomoro yamohala: 051 405 2812 ha o na le dipotso ka ditokelo tsa hao jwalo ka monka karolo 
dipatlisisong. 
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Correspondence 
 
Date: Tuesday, 10 March 2009 
Dr N v Zyl 
CEO: Universitas Academic Hospital 
Bloemfontein 9300 
Dear Dr van Zyl 
RE:  Reference Echocardiographic measurements for premature and newborn infants of the Free State & 
Northern Cape 
I would like to apply for approval of the above project (ETOVS: ) and provide the following details for your 
perusal: 
1) I am the chief researcher for this project. 
2) This is a study to evaluate normal echocardiographic chamber size in healthy premature infants 
3) The study will take place within the domain of paediatrics 
4) This is an echocardiographic study, non painful and with no effect on patient 
5) Duration : roughly 4-6months 
6) The results will be published and presented. 
7) There is no additional cost to either the patient or the hospital. 
8) I include a protocol for your perusal. 
 
Regards 
PROF SC BROWN 
HEAD:  PAEDIATRIC CARDIOLOGY 
------------------------------------------------------------------------------------------------------------------------------------ 
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Date: Tuesday, 10 March 2009 
 
Mr L Bekker 
CEO: Mediclinic Hospital 
Bloemfontein 9300 
 
Dear Mr Bekker 
RE:  Reference Echocardiographic measurements for premature and newborn infants of the Free State & 
Northern Cape 
I would like to apply for approval of the above project (ETOVS: ) and provide the following details for your 
perusal: 
9) I am the chief researcher for this project. 
10) This is a study to evaluate normal echocardiographic chamber size in healthy premature infants 
11) The study will take place within the domain of paediatrics 
12) This is an echocardiographic study, non painful and with no effect on patient 
13) Duration : roughly 4-6months 
14) The results will be published and presented. 
15) There is no additional cost to either the patient or the hospital. 
16) I include a protocol for your perusal. 
 
Regards 
 
 
PROF SC BROWN 
HEAD:  PAEDIATRIC CARDIOLOGY 
 
 
-------------------------------------------------------------------------------------------------------------------------------------- 
Date: Tuesday, 10 March 2009 
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Mr C Buhrmann 
CEO: Rosepark Hospital 
Bloemfontein 9300 
Dear Mr Buhrmann 
 
RE:  Reference Echocardiographic measurements for premature and newborn infants of the Free State & 
Northern Cape 
I would like to apply for approval of the above project (ETOVS: ) and provide the following details for your 
perusal: 
17) I am the chief researcher for this project. 
18) This is a study to evaluate normal echocardiographic chamber size in healthy premature infants 
19) The study will take place within the domain of paediatrics 
20) This is an echocardiographic study, non painful and with no effect on patient 
21) Duration : roughly 4-6months 
22) The results will be published and presented. 
23) There is no additional cost to either the patient or the hospital. 
24) I include a protocol for your perusal. 
 
Regards 
 
 
PROF SC BROWN 
HEAD:  PAEDIATRIC CARDIOLOGY 
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LOCATION OF MEASUREMENTS 
 
 
Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantification in M-Mode 
echocardiography : results of a survey of echocardiography measurements. Circulation 1978; 6; 1-72-1081 
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Ballard Scoring Method 
ASSESSING GESTATIONAL AGE BY SIMPLE INSPECTION. 
There are a number of easily observable clinical signs that can help you decide whether an infant is term or preterm: 
TERM  PRETERM 
Sucks well. 
Yes No 
Flexes arms and legs. 
Yes  No 
Veins seen under skin. 
No Yes 
Nipple clearly seen. 
Yes  No 
Palpable breast bud. 
Yes  No 
Descended testes. 
Yes  No 
Covered labia minora. 
Yes  No 
 
SCORING GESTATIONAL AGE. 
The Ballard scoring method 
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The accuracy of the method depends on the experience of the examiner. With practice and careful attention to 
detail, the infant's true gestational age can be estimated with an accuracy of about 2 weeks. If the scored age 
is within 2 weeks of the gestational age suggested by the mother's dates, then accept her dates as correct. 
However, if the scored age is more than 2 weeks higher or lower than the mother's dates, then her dates are 
probably incorrect and the scored age should be used. The scored gestational age can also be used to decide 
whether the gestational age, determined by obstetric assessment, is correct or not. 
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